Document_and_Entity_Informatio
Document and Entity Information | 6 Months Ended | |
In Thousands, unless otherwise specified | Mar. 28, 2015 | Apr. 10, 2015 |
Document Type | 10-Q | |
Amendment Flag | FALSE | |
Document Period End Date | 28-Mar-15 | |
Document Fiscal Year Focus | 2015 | |
Document Fiscal Period Focus | Q2 | |
Trading Symbol | AAPL | |
Entity Registrant Name | APPLE INC | |
Entity Central Index Key | 320193 | |
Current Fiscal Year End Date | -17 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 5,761,030 |
CONDENSED_CONSOLIDATED_STATEME
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, except Share data in Thousands, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Net sales | $58,010 | $45,646 | $132,609 | $103,240 |
Cost of sales | 34,354 | 27,699 | 79,212 | 63,447 |
Gross margin | 23,656 | 17,947 | 53,397 | 39,793 |
Operating expenses: | ||||
Research and development | 1,918 | 1,422 | 3,813 | 2,752 |
Selling, general and administrative | 3,460 | 2,932 | 7,060 | 5,985 |
Total operating expenses | 5,378 | 4,354 | 10,873 | 8,737 |
Operating income | 18,278 | 13,593 | 42,524 | 31,056 |
Other income/(expense), net | 286 | 225 | 456 | 471 |
Income before provision for income taxes | 18,564 | 13,818 | 42,980 | 31,527 |
Provision for income taxes | 4,995 | 3,595 | 11,387 | 8,232 |
Net income | $13,569 | $10,223 | $31,593 | $23,295 |
Earnings per share: | ||||
Basic | $2.34 | $1.67 | $5.43 | $3.76 |
Diluted | $2.33 | $1.66 | $5.39 | $3.74 |
Shares used in computing earnings per share: | ||||
Basic | 5,793,799 | 6,123,302 | 5,818,441 | 6,197,903 |
Diluted | 5,834,858 | 6,156,699 | 5,858,330 | 6,233,430 |
Cash dividends declared per share | $0.47 | $0.44 | $0.94 | $0.88 |
CONDENSED_CONSOLIDATED_STATEME1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Net income | $13,569 | $10,223 | $31,593 | $23,295 |
Other comprehensive income: | ||||
Change in foreign currency translation, net of tax | -180 | -19 | -246 | -86 |
Change in unrealized gains/losses on derivative instruments: | ||||
Change in fair value of derivatives, net of tax | 1,037 | -109 | 3,019 | 104 |
Adjustment for net (gains)/losses realized and included in net income, net of tax | -739 | -13 | -1,304 | 59 |
Total change in unrealized gains/losses on derivative instruments, net of tax | 298 | -122 | 1,715 | 163 |
Change in unrealized gains/losses on marketable securities: | ||||
Change in fair value of marketable securities, net of tax | 593 | 235 | 137 | 193 |
Adjustment for net (gains)/losses realized and included in net income, net of tax | 36 | -39 | 22 | -50 |
Total change in unrealized gains/losses on marketable securities, net of tax | 629 | 196 | 159 | 143 |
Total other comprehensive income/(loss) | 747 | 55 | 1,628 | 220 |
Total comprehensive income | $14,316 | $10,278 | $33,221 | $23,515 |
CONDENSED_CONSOLIDATED_BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) | Mar. 28, 2015 | Sep. 27, 2014 |
In Millions, unless otherwise specified | ||
Current assets: | ||
Cash and cash equivalents | $14,489 | $13,844 |
Short-term marketable securities | 18,607 | 11,233 |
Accounts receivable, less allowances of $83 and $86, respectively | 10,905 | 17,460 |
Inventories | 2,396 | 2,111 |
Deferred tax assets | 5,141 | 4,318 |
Vendor non-trade receivables | 7,259 | 9,759 |
Other current assets | 9,094 | 9,806 |
Total current assets | 67,891 | 68,531 |
Long-term marketable securities | 160,443 | 130,162 |
Property, plant and equipment, net | 20,151 | 20,624 |
Goodwill | 4,711 | 4,616 |
Acquired intangible assets, net | 4,061 | 4,142 |
Other assets | 3,937 | 3,764 |
Total assets | 261,194 | 231,839 |
Current liabilities: | ||
Accounts payable | 23,159 | 30,196 |
Accrued expenses | 22,827 | 18,453 |
Deferred revenue | 8,944 | 8,491 |
Commercial paper | 3,799 | 6,308 |
Total current liabilities | 58,729 | 63,448 |
Deferred revenue - non-current | 3,571 | 3,031 |
Long-term debt | 40,072 | 28,987 |
Other non-current liabilities | 29,816 | 24,826 |
Total liabilities | 132,188 | 120,292 |
Commitments and contingencies | ||
Shareholders' equity: | ||
Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 5,762,278 and 5,866,161 shares issued and outstanding, respectively | 25,376 | 23,313 |
Retained earnings | 100,920 | 87,152 |
Accumulated other comprehensive income | 2,710 | 1,082 |
Total shareholders' equity | 129,006 | 111,547 |
Total liabilities and shareholders' equity | $261,194 | $231,839 |
CONDENSED_CONSOLIDATED_BALANCE1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 |
In Millions, except Share data, unless otherwise specified | ||
Accounts receivable, allowances | $83 | $86 |
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 12,600,000,000 | 12,600,000,000 |
Common stock, shares issued | 5,762,278,000 | 5,866,161,000 |
Common stock, shares outstanding | 5,762,278,000 | 5,866,161,000 |
CONDENSED_CONSOLIDATED_STATEME2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 6 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Cash and cash equivalents, beginning of the period | $13,844 | $14,259 |
Operating activities: | ||
Net income | 31,593 | 23,295 |
Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 5,054 | 4,031 |
Share-based compensation expense | 1,815 | 1,377 |
Deferred income tax expense | 1,879 | 2,059 |
Changes in operating assets and liabilities: | ||
Accounts receivable, net | 6,555 | 3,401 |
Inventories | -285 | -65 |
Vendor non-trade receivables | 2,500 | 1,419 |
Other current and non-current assets | 2,448 | 14 |
Accounts payable | -5,428 | -2,375 |
Deferred revenue | 993 | 1,414 |
Other current and non-current liabilities | 5,679 | 1,638 |
Cash generated by operating activities | 52,803 | 36,208 |
Investing activities: | ||
Purchases of marketable securities | -92,523 | -90,360 |
Proceeds from maturities of marketable securities | 5,871 | 10,869 |
Proceeds from sales of marketable securities | 48,924 | 80,241 |
Payments made in connection with business acquisitions, net | -115 | -559 |
Payments for acquisition of property, plant and equipment | -5,586 | -3,367 |
Payments for acquisition of intangible assets | -155 | -163 |
Other | 88 | -23 |
Cash used in investing activities | -43,496 | -3,362 |
Financing activities: | ||
Proceeds from issuance of common stock | 309 | 341 |
Excess tax benefits from equity awards | 357 | 363 |
Taxes paid related to net share settlement of equity awards | -608 | -430 |
Dividends and dividend equivalents paid | -5,544 | -5,430 |
Repurchase of common stock | -12,000 | -23,000 |
Proceeds from issuance of long-term debt, net | 11,332 | 0 |
Repayments of commercial paper, net | -2,508 | 0 |
Cash used in financing activities | -8,662 | -28,156 |
Increase in cash and cash equivalents | 645 | 4,690 |
Cash and cash equivalents, end of the period | 14,489 | 18,949 |
Supplemental cash flow disclosure: | ||
Cash paid for income taxes, net | 7,058 | 5,369 |
Cash paid for interest | $220 | $161 |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Summary of Significant Accounting Policies | Note 1 – Summary of Significant Accounting Policies | ||||||||||||||||
Apple Inc. and its wholly-owned subsidiaries (collectively “Apple” or the “Company”) designs, manufactures and markets mobile communication and media devices, personal computers and portable digital music players, and sells a variety of related software, services, accessories, networking solutions and third-party digital content and applications. The Company sells its products worldwide through its retail stores, online stores and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the Company sells a variety of third-party iPhone, iPad, Mac and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses and education, enterprise and government customers. | |||||||||||||||||
Basis of Presentation and Preparation | |||||||||||||||||
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. | |||||||||||||||||
These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto for the fiscal year ended September 27, 2014, included in its Annual Report on Form 10-K as updated by the Company’s Current Report on Form 8-K dated January 28, 2015 (hereinafter, the “2014 Form 10-K”). The Company’s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company’s fiscal years 2015 and 2014 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or months refer to the Company’s fiscal years ended in September and the associated quarters or months of those fiscal years. | |||||||||||||||||
Earnings Per Share | |||||||||||||||||
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan, unvested restricted stock and unvested restricted stock units (“RSUs”). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s common stock can result in a greater dilutive effect from potentially dilutive securities. | |||||||||||||||||
The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (net income in millions and shares in thousands): | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Numerator: | |||||||||||||||||
Net income | $ | 13,569 | $ | 10,223 | $ | 31,593 | $ | 23,295 | |||||||||
Denominator: | |||||||||||||||||
Weighted-average shares outstanding | 5,793,799 | 6,123,302 | 5,818,441 | 6,197,903 | |||||||||||||
Effect of dilutive securities | 41,059 | 33,397 | 39,889 | 35,527 | |||||||||||||
Weighted-average diluted shares | 5,834,858 | 6,156,699 | 5,858,330 | 6,233,430 | |||||||||||||
Basic earnings per share | $ | 2.34 | $ | 1.67 | $ | 5.43 | $ | 3.76 | |||||||||
Diluted earnings per share | $ | 2.33 | $ | 1.66 | $ | 5.39 | $ | 3.74 | |||||||||
Potentially dilutive securities, whose effect would have been antidilutive, were not significant for the three- and six-month periods ended March 28, 2015 and the three- and six-month periods ended March 29, 2014. The Company excluded these securities from the computation of diluted earnings per share. |
Financial_Instruments
Financial Instruments | 6 Months Ended | ||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||
Financial Instruments | Note 2 – Financial Instruments | ||||||||||||||||||||||||||||
Cash, Cash Equivalents and Marketable Securities | |||||||||||||||||||||||||||||
The following tables show the Company’s cash and available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of March 28, 2015 and September 27, 2014 (in millions): | |||||||||||||||||||||||||||||
March 28, 2015 | |||||||||||||||||||||||||||||
Adjusted | Unrealized | Unrealized | Fair | Cash and | Short-Term | Long-Term | |||||||||||||||||||||||
Cost | Gains | Losses | Value | Cash | Marketable | Marketable | |||||||||||||||||||||||
Equivalents | Securities | Securities | |||||||||||||||||||||||||||
Cash | $ | 9,879 | $ | 0 | $ | 0 | $ | 9,879 | $ | 9,879 | $ | 0 | $ | 0 | |||||||||||||||
Level 1 (1): | |||||||||||||||||||||||||||||
Money market funds | 1,457 | 0 | 0 | 1,457 | 1,457 | 0 | 0 | ||||||||||||||||||||||
Mutual funds | 2,384 | 0 | (126 | ) | 2,258 | 0 | 2,258 | 0 | |||||||||||||||||||||
Subtotal | 3,841 | 0 | (126 | ) | 3,715 | 1,457 | 2,258 | 0 | |||||||||||||||||||||
Level 2 (2): | |||||||||||||||||||||||||||||
U.S. Treasury securities | 42,854 | 145 | (12 | ) | 42,987 | 0 | 1,791 | 41,196 | |||||||||||||||||||||
U.S. agency securities | 6,901 | 11 | (2 | ) | 6,910 | 585 | 1,056 | 5,269 | |||||||||||||||||||||
Non-U.S. government securities | 7,114 | 86 | (80 | ) | 7,120 | 41 | 271 | 6,808 | |||||||||||||||||||||
Certificates of deposit and time deposits | 3,473 | 0 | 0 | 3,473 | 1,163 | 1,252 | 1,058 | ||||||||||||||||||||||
Commercial paper | 2,956 | 0 | 0 | 2,956 | 1,364 | 1,592 | 0 | ||||||||||||||||||||||
Corporate securities | 100,658 | 427 | (370 | ) | 100,715 | 0 | 10,325 | 90,390 | |||||||||||||||||||||
Municipal securities | 942 | 5 | (1 | ) | 946 | 0 | 24 | 922 | |||||||||||||||||||||
Mortgage- and asset-backed securities | 14,782 | 75 | (19 | ) | 14,838 | 0 | 38 | 14,800 | |||||||||||||||||||||
Subtotal | 179,680 | 749 | (484 | ) | 179,945 | 3,153 | 16,349 | 160,443 | |||||||||||||||||||||
Total | $ | 193,400 | $ | 749 | $ | (610 | ) | $ | 193,539 | $ | 14,489 | $ | 18,607 | $ | 160,443 | ||||||||||||||
September 27, 2014 | |||||||||||||||||||||||||||||
Adjusted | Unrealized | Unrealized | Fair | Cash and | Short-Term | Long-Term | |||||||||||||||||||||||
Cost | Gains | Losses | Value | Cash | Marketable | Marketable | |||||||||||||||||||||||
Equivalents | Securities | Securities | |||||||||||||||||||||||||||
Cash | $ | 10,232 | $ | 0 | $ | 0 | $ | 10,232 | $ | 10,232 | $ | 0 | $ | 0 | |||||||||||||||
Level 1 (1): | |||||||||||||||||||||||||||||
Money market funds | 1,546 | 0 | 0 | 1,546 | 1,546 | 0 | 0 | ||||||||||||||||||||||
Mutual funds | 2,531 | 1 | (132 | ) | 2,400 | 0 | 2,400 | 0 | |||||||||||||||||||||
Subtotal | 4,077 | 1 | (132 | ) | 3,946 | 1,546 | 2,400 | 0 | |||||||||||||||||||||
Level 2 (2): | |||||||||||||||||||||||||||||
U.S. Treasury securities | 23,140 | 15 | (9 | ) | 23,146 | 12 | 607 | 22,527 | |||||||||||||||||||||
U.S. agency securities | 7,373 | 3 | (11 | ) | 7,365 | 652 | 157 | 6,556 | |||||||||||||||||||||
Non-U.S. government securities | 6,925 | 69 | (69 | ) | 6,925 | 0 | 204 | 6,721 | |||||||||||||||||||||
Certificates of deposit and time deposits | 3,832 | 0 | 0 | 3,832 | 1,230 | 1,233 | 1,369 | ||||||||||||||||||||||
Commercial paper | 475 | 0 | 0 | 475 | 166 | 309 | 0 | ||||||||||||||||||||||
Corporate securities | 85,431 | 296 | (241 | ) | 85,486 | 6 | 6,298 | 79,182 | |||||||||||||||||||||
Municipal securities | 940 | 8 | 0 | 948 | 0 | 0 | 948 | ||||||||||||||||||||||
Mortgage- and asset-backed securities | 12,907 | 26 | (49 | ) | 12,884 | 0 | 25 | 12,859 | |||||||||||||||||||||
Subtotal | 141,023 | 417 | (379 | ) | 141,061 | 2,066 | 8,833 | 130,162 | |||||||||||||||||||||
Total | $ | 155,332 | $ | 418 | $ | (511 | ) | $ | 155,239 | $ | 13,844 | $ | 11,233 | $ | 130,162 | ||||||||||||||
(1) | The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities. | ||||||||||||||||||||||||||||
(2) | The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. | ||||||||||||||||||||||||||||
The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014. The maturities of the Company’s long-term marketable securities generally range from one to five years. | |||||||||||||||||||||||||||||
As of March 28, 2015 and September 27, 2014, gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant. | |||||||||||||||||||||||||||||
During the three- and six-month periods ended March 28, 2015 and March 29, 2014, the Company did not recognize any significant impairment charges. As of March 28, 2015, the Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company’s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment’s cost basis. | |||||||||||||||||||||||||||||
Derivative Financial Instruments | |||||||||||||||||||||||||||||
The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. | |||||||||||||||||||||||||||||
To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. | |||||||||||||||||||||||||||||
To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. The Company designates these instruments as net investment hedges. | |||||||||||||||||||||||||||||
The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. | |||||||||||||||||||||||||||||
The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company’s long-term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company’s hedged interest rate transactions as of March 28, 2015 are expected to be recognized within 12 years. | |||||||||||||||||||||||||||||
Cash Flow Hedges | |||||||||||||||||||||||||||||
The effective portions of cash flow hedges are recorded in accumulated other comprehensive income (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. | |||||||||||||||||||||||||||||
The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. These amounts were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014. | |||||||||||||||||||||||||||||
Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three- and six-month periods ended March 28, 2015 and March 29, 2014. | |||||||||||||||||||||||||||||
Net Investment Hedges | |||||||||||||||||||||||||||||
The effective portions of net investment hedges are recorded in other comprehensive income (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. These amounts were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014. | |||||||||||||||||||||||||||||
Fair Value Hedges | |||||||||||||||||||||||||||||
Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item. The ineffective portions and amounts excluded from the effectiveness testing of fair value hedges recognized were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014. | |||||||||||||||||||||||||||||
Non-Designated Derivatives | |||||||||||||||||||||||||||||
Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. The net gains and losses recognized for foreign currency forward and option contracts not designated as hedging instruments were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014. | |||||||||||||||||||||||||||||
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company’s derivative instruments at gross fair value as of March 28, 2015 and September 27, 2014 (in millions): | |||||||||||||||||||||||||||||
March 28, 2015 | |||||||||||||||||||||||||||||
Fair Value of | Fair Value of | Total | |||||||||||||||||||||||||||
Derivatives | Derivatives Not | Fair Value | |||||||||||||||||||||||||||
Designated as | Designated as | ||||||||||||||||||||||||||||
Hedge Instruments | Hedge Instruments | ||||||||||||||||||||||||||||
Derivative assets (1): | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 3,045 | $ | 86 | $ | 3,131 | |||||||||||||||||||||||
Interest rate contracts | $ | 329 | $ | 0 | $ | 329 | |||||||||||||||||||||||
Derivative liabilities (2): | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 27 | $ | 91 | $ | 118 | |||||||||||||||||||||||
Interest rate contracts | $ | 458 | $ | 0 | $ | 458 | |||||||||||||||||||||||
September 27, 2014 | |||||||||||||||||||||||||||||
Fair Value of | Fair Value of | Total | |||||||||||||||||||||||||||
Derivatives | Derivatives Not | Fair Value | |||||||||||||||||||||||||||
Designated as | Designated as | ||||||||||||||||||||||||||||
Hedge Instruments | Hedge Instruments | ||||||||||||||||||||||||||||
Derivative assets (1): | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 1,332 | $ | 222 | $ | 1,554 | |||||||||||||||||||||||
Interest rate contracts | $ | 81 | $ | 0 | $ | 81 | |||||||||||||||||||||||
Derivative liabilities (2): | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 41 | $ | 40 | $ | 81 | |||||||||||||||||||||||
(1) | The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets. | ||||||||||||||||||||||||||||
(2) | The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets. | ||||||||||||||||||||||||||||
The following tables show the pre-tax gains and losses of the Company’s derivative instruments designated as cash flow, net investment and fair value hedges on OCI and the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | |||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||||||||||||||
Gains/(Losses) recognized in OCI – effective portion: | |||||||||||||||||||||||||||||
Cash flow hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 1,591 | $ | (121 | ) | $ | 4,176 | $ | 143 | ||||||||||||||||||||
Interest rate contracts | (429 | ) | (27 | ) | (517 | ) | (6 | ) | |||||||||||||||||||||
Total | $ | 1,162 | $ | (148 | ) | $ | 3,659 | $ | 137 | ||||||||||||||||||||
Net investment hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | (6 | ) | $ | (19 | ) | $ | 112 | $ | 5 | |||||||||||||||||||
Gains/(Losses) reclassified from AOCI into net income – effective portion: | |||||||||||||||||||||||||||||
Cash flow hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 1,166 | $ | 22 | $ | 1,928 | $ | (52 | ) | ||||||||||||||||||||
Interest rate contracts | (353 | ) | (4 | ) | (452 | ) | (8 | ) | |||||||||||||||||||||
Total | $ | 813 | $ | 18 | $ | 1,476 | $ | (60 | ) | ||||||||||||||||||||
Gains/(Losses) on derivative instruments: | |||||||||||||||||||||||||||||
Fair value hedges: | |||||||||||||||||||||||||||||
Interest rate contracts | $ | 122 | $ | 0 | $ | 239 | $ | 0 | |||||||||||||||||||||
Gains/(Losses) related to hedged items: | |||||||||||||||||||||||||||||
Fair value hedges: | |||||||||||||||||||||||||||||
Interest rate contracts | $ | (122 | ) | $ | 0 | $ | (239 | ) | $ | 0 | |||||||||||||||||||
The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of March 28, 2015 and September 27, 2014 (in millions): | |||||||||||||||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||||||||||||||
Notional | Credit Risk | Notional | Credit Risk | ||||||||||||||||||||||||||
Amount | Amounts | Amount | Amounts | ||||||||||||||||||||||||||
Instruments designated as accounting hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 37,855 | $ | 3,045 | $ | 42,945 | $ | 1,333 | |||||||||||||||||||||
Interest rate contracts | $ | 18,013 | $ | 329 | $ | 12,000 | $ | 89 | |||||||||||||||||||||
Instruments not designated as accounting hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 27,486 | $ | 86 | $ | 38,510 | $ | 222 | |||||||||||||||||||||
The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company’s exposure to credit or market loss. The credit risk amounts represent the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company’s exposure to credit loss and market risk will vary over time as currency and interest rates change. Although the table above reflects the notional and credit risk amounts of the Company’s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. | |||||||||||||||||||||||||||||
The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values in its Condensed Consolidated Balance Sheets. As of March 28, 2015 and September 27, 2014, the Company received $3.7 billion and $2.1 billion, respectively, of cash collateral related to the derivative instruments under its collateral security arrangements, which were recorded as other current liabilities within accrued expenses in the Condensed Consolidated Balance Sheets. The Company did not have any derivative instruments with credit-risk related contingent features that would require it to post additional collateral as of March 28, 2015 and September 27, 2014. | |||||||||||||||||||||||||||||
Under master netting arrangements with the respective counterparties to the Company’s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by one party to the other. As of March 28, 2015 and September 27, 2014, the potential effects of these rights of set-off associated with the Company’s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $3.6 billion and $1.6 billion, respectively, resulting in net derivative liabilities of $859 million and $549 million, respectively. | |||||||||||||||||||||||||||||
Accounts Receivable | |||||||||||||||||||||||||||||
Trade Receivables | |||||||||||||||||||||||||||||
The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, value-added resellers, small and mid-sized businesses and education, enterprise and government customers that are not covered by collateral, third-party financing arrangements or credit insurance. As of March 28, 2015, the Company had one customer that represented 10% or more of total trade receivables, which accounted for 11%. As of September 27, 2014, the Company had two customers that represented 10% or more of total trade receivables, one of which accounted for 16% and the other 13%. The Company’s cellular network carriers accounted for 63% and 72% of trade receivables as of March 28, 2015 and September 27, 2014, respectively. | |||||||||||||||||||||||||||||
Vendor Non-Trade Receivables | |||||||||||||||||||||||||||||
Additionally, the Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture sub-assemblies or assemble final products for the Company. Vendor non-trade receivables from three of the Company’s vendors accounted for 48%, 18% and 16% of total vendor non-trade receivables as of March 28, 2015 and three of the Company’s vendors accounted for 51%, 16% and 14% of total vendor non-trade receivables as of September 27, 2014. |
Condensed_Consolidated_Financi
Condensed Consolidated Financial Statement Details | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Condensed Consolidated Financial Statement Details | Note 3 – Condensed Consolidated Financial Statement Details | ||||||||||||||||
The following tables show the Company’s condensed consolidated financial statement details as of March 28, 2015 and September 27, 2014 (in millions): | |||||||||||||||||
Inventories | |||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Components | $ | 537 | $ | 471 | |||||||||||||
Finished goods | 1,859 | 1,640 | |||||||||||||||
Total inventories | $ | 2,396 | $ | 2,111 | |||||||||||||
Property, Plant and Equipment, Net | |||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Land and buildings | $ | 5,627 | $ | 4,863 | |||||||||||||
Machinery, equipment and internal-use software | 32,107 | 29,639 | |||||||||||||||
Leasehold improvements | 4,726 | 4,513 | |||||||||||||||
Gross property, plant and equipment | 42,460 | 39,015 | |||||||||||||||
Accumulated depreciation and amortization | (22,309 | ) | (18,391 | ) | |||||||||||||
Total property, plant and equipment, net | $ | 20,151 | $ | 20,624 | |||||||||||||
Accrued Expenses | |||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Accrued warranty and related costs | $ | 5,143 | $ | 4,159 | |||||||||||||
Accrued taxes | 2,017 | 1,209 | |||||||||||||||
Accrued marketing and selling expenses | 1,384 | 2,321 | |||||||||||||||
Accrued compensation and employee benefits | 1,254 | 1,209 | |||||||||||||||
Deferred margin on component sales | 1,130 | 1,057 | |||||||||||||||
Other current liabilities | 11,899 | 8,498 | |||||||||||||||
Total accrued expenses | $ | 22,827 | $ | 18,453 | |||||||||||||
Other Non-Current Liabilities | |||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Deferred tax liabilities | $ | 23,825 | $ | 20,259 | |||||||||||||
Other non-current liabilities | 5,991 | 4,567 | |||||||||||||||
Total other non-current liabilities | $ | 29,816 | $ | 24,826 | |||||||||||||
Other Income/(Expense), Net | |||||||||||||||||
The following table shows the detail of other income/(expense), net for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, 2015 | March 29, 2014 | March 28, 2015 | March 29, 2014 | ||||||||||||||
Interest and dividend income | $ | 675 | $ | 410 | $ | 1,329 | $ | 837 | |||||||||
Interest expense | (163 | ) | (85 | ) | (294 | ) | (169 | ) | |||||||||
Other expense, net | (226 | ) | (100 | ) | (579 | ) | (197 | ) | |||||||||
Total other income/(expense), net | $ | 286 | $ | 225 | $ | 456 | $ | 471 | |||||||||
Goodwill_and_Other_Intangible_
Goodwill and Other Intangible Assets | 6 Months Ended | ||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||
Goodwill and Other Intangible Assets | Note 4 – Goodwill and Other Intangible Assets | ||||||||||||||||||||||||
The Company’s acquired intangible assets with definite useful lives primarily consist of patents and licenses and are amortized over periods typically from three to seven years. The following table summarizes the components of gross and net intangible asset balances as of March 28, 2015 and September 27, 2014 (in millions): | |||||||||||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||||||||||
Gross | Accumulated | Net | Gross | Accumulated | Net | ||||||||||||||||||||
Carrying | Amortization | Carrying | Carrying | Amortization | Carrying | ||||||||||||||||||||
Amount | Amount | Amount | Amount | ||||||||||||||||||||||
Definite-lived and amortizable acquired intangible assets | $ | 7,672 | $ | (3,711 | ) | $ | 3,961 | $ | 7,127 | $ | (3,085 | ) | $ | 4,042 | |||||||||||
Indefinite-lived and non-amortizable acquired intangible assets | 100 | 0 | 100 | 100 | 0 | 100 | |||||||||||||||||||
Total acquired intangible assets | $ | 7,772 | $ | (3,711 | ) | $ | 4,061 | $ | 7,227 | $ | (3,085 | ) | $ | 4,142 | |||||||||||
Income_Taxes
Income Taxes | 6 Months Ended |
Mar. 28, 2015 | |
Income Taxes | Note 5 – Income Taxes |
As of March 28, 2015, the Company recorded gross unrecognized tax benefits of $4.6 billion, of which $1.6 billion, if recognized, would affect the Company’s effective tax rate. As of September 27, 2014, the total amount of gross unrecognized tax benefits was $4.0 billion, of which $1.4 billion, if recognized, would have affected the Company’s effective tax rate. The Company’s total gross unrecognized tax benefits are classified as other non-current liabilities in the Condensed Consolidated Balance Sheets. The Company had $844 million and $630 million of gross interest and penalties accrued as of March 28, 2015 and September 27, 2014, respectively, which are classified as other non-current liabilities in the Condensed Consolidated Balance Sheets. | |
Management believes that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with management’s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. Although timing of the resolution and/or closure of audits is not certain, the Company does not believe it is reasonably possible that its unrecognized tax benefits would materially change in the next 12 months. | |
On June 11, 2014, the European Commission issued an opening decision initiating a formal investigation against Ireland for alleged state aid to the Company. The opening decision concerns the allocation of profits for taxation purposes of the Irish branches of two subsidiaries of the Company. The Company believes the European Commission’s assertions are without merit. If the European Commission were to conclude against Ireland, the European Commission could require Ireland to recover from the Company past taxes covering a period of up to 10 years reflective of the disallowed state aid. While such amount could be material, as of March 28, 2015 the Company is unable to estimate the impact. |
Debt
Debt | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Debt | Note 6 – Debt | ||||||||||||||||
Commercial Paper | |||||||||||||||||
In 2014, the Board of Directors authorized the Company to issue unsecured short-term promissory notes (“Commercial Paper”) pursuant to a commercial paper program. The Company intends to use net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of March 28, 2015 and September 27, 2014, the Company had $3.8 billion and $6.3 billion of Commercial Paper outstanding, respectively, with a weighted-average interest rate of 0.10% and 0.12%, respectively, and maturities generally less than nine months. | |||||||||||||||||
The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the six months ended March 28, 2015 (in millions): | |||||||||||||||||
Maturities less than 90 days: | |||||||||||||||||
Proceeds from (repayments of) commercial paper, net | $ | 985 | |||||||||||||||
Maturities greater than 90 days: | |||||||||||||||||
Proceeds from commercial paper | 547 | ||||||||||||||||
Repayments of commercial paper | (4,040 | ) | |||||||||||||||
Maturities greater than 90 days, net | (3,493 | ) | |||||||||||||||
Total repayments of commercial paper, net | $ | (2,508 | ) | ||||||||||||||
Long-Term Debt | |||||||||||||||||
As of March 28, 2015, the Company has outstanding floating- and fixed-rate notes with varying maturities for an aggregate principal amount of $39.9 billion (collectively the “Notes”). The Notes are senior unsecured obligations, and interest is payable in arrears, quarterly for the domestic floating-rate notes, semi-annually for the domestic fixed-rate notes and annually for the foreign fixed-rate notes. The following table provides a summary of the Company’s long-term debt as of March 28, 2015 and September 27, 2014: | |||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Amount | Effective | Amount | Effective | ||||||||||||||
(in millions) | Interest Rate | (in millions) | Interest Rate | ||||||||||||||
Floating-rate notes due 2016 (1) | $ | 1,000 | 0.51% | $ | 1,000 | 0.51% | |||||||||||
Floating-rate notes due 2017 (2) | 1,000 | 0.33% | 1,000 | 0.31% | |||||||||||||
Floating-rate notes due 2018 (1) | 2,000 | 1.10% | 2,000 | 1.10% | |||||||||||||
Floating-rate notes due 2019 (2) | 1,000 | 0.56% | 1,000 | 0.54% | |||||||||||||
Floating-rate notes due 2020 (3) | 500 | 0.51% | 0 | 0 | |||||||||||||
Fixed-rate 0.45% notes due 2016 (1) | 1,500 | 0.51% | 1,500 | 0.51% | |||||||||||||
Fixed-rate 1.05% notes due 2017 (2) | 1,500 | 0.32% | 1,500 | 0.30% | |||||||||||||
Fixed-rate 1.00% notes due 2018 (1) | 4,000 | 1.08% | 4,000 | 1.08% | |||||||||||||
Fixed-rate 2.10% notes due 2019 (2) | 2,000 | 0.55% | 2,000 | 0.53% | |||||||||||||
Fixed-rate 1.55% notes due 2020 (3) | 1,250 | 0.50% | 0 | 0 | |||||||||||||
Fixed-rate 2.85% notes due 2021 (2) | 3,000 | 0.81% | 3,000 | 0.79% | |||||||||||||
Fixed-rate 2.15% notes due 2022 (3) | 1,250 | 0.82% | 0 | 0 | |||||||||||||
Fixed-rate 1.00% Euro-denominated notes due 2022 (4) | 1,534 | 2.94% | 0 | 0 | |||||||||||||
Fixed-rate 2.40% notes due 2023 (1) | 5,500 | 2.44% | 5,500 | 2.44% | |||||||||||||
Fixed-rate 3.45% notes due 2024 (2) | 2,500 | 0.92% | 2,500 | 0.90% | |||||||||||||
Fixed-rate 0.38% Swiss Franc-denominated notes due 2024 (5) | 915 | 0.28% | 0 | 0 | |||||||||||||
Fixed-rate 2.50% notes due 2025 (3) | 1,500 | 2.60% | 0 | 0 | |||||||||||||
Fixed-rate 1.63% Euro-denominated notes due 2026 (4) | 1,534 | 3.45% | 0 | 0 | |||||||||||||
Fixed-rate 0.75% Swiss Franc-denominated notes due 2030 (5) | 392 | 0.74% | 0 | 0 | |||||||||||||
Fixed-rate 3.85% notes due 2043 (1) | 3,000 | 3.91% | 3,000 | 3.91% | |||||||||||||
Fixed-rate 4.45% notes due 2044 (2) | 1,000 | 4.48% | 1,000 | 4.48% | |||||||||||||
Fixed-rate 3.45% notes due 2045 (3) | 2,000 | 3.58% | 0 | 0 | |||||||||||||
Total borrowings | 39,875 | 29,000 | |||||||||||||||
Unamortized discount | (80 | ) | (52 | ) | |||||||||||||
Hedge accounting fair value adjustments | 277 | 39 | |||||||||||||||
Total long-term debt | $ | 40,072 | $ | 28,987 | |||||||||||||
(1) | Tranche relates to the $17.0 billion debt issuance in the third quarter of 2013. | ||||||||||||||||
(2) | Tranche relates to the $12.0 billion debt issuance in the third quarter of 2014. | ||||||||||||||||
(3) | Tranche relates to the $6.5 billion debt issuance in the second quarter of 2015. | ||||||||||||||||
(4) | Tranche relates to Euro-denominated debt issuance of €2.8 billion in the first quarter of 2015. | ||||||||||||||||
(5) | Tranche relates to Swiss Franc-denominated debt issuance of SFr1.3 billion in the second quarter of 2015. | ||||||||||||||||
During the first six months of 2015, the Company issued €2.8 billion of Euro-denominated notes, $6.5 billion of U.S. dollar-denominated notes and SFr1.3 billion of Swiss Franc-denominated notes. To manage foreign currency risk associated with the Euro-denominated notes, the Company entered into currency swaps with an aggregate notional amount of $3.5 billion, which effectively converted the Euro-denominated notes to U.S. dollar-denominated notes. To manage interest rate risk on the U.S. dollar-denominated fixed-rate notes maturing in 2020 and 2022, the Company entered into interest rate swaps with an aggregate notional amount of $2.5 billion, which effectively converted the fixed interest rates on these notes to a floating interest rate. For further discussion regarding the Company’s use of derivative instruments to manage interest rate and foreign currency risk, see the Derivative Financial Instruments section of Note 2, “Financial Instruments.” | |||||||||||||||||
The effective interest rates for the Notes include the interest on the Notes, amortization of the discount and, if applicable, adjustments related to hedging. The Company recognized $161 million and $289 million of interest expense on its long-term debt for the three- and six-month periods ended March 28, 2015, respectively. The Company recognized $84 million and $168 million of interest expense on its long-term debt for the three- and six-month periods ended March 29, 2014, respectively. | |||||||||||||||||
Future principal payments for the Company’s Notes as of March 28, 2015 are as follows (in millions): | |||||||||||||||||
2015 | $ | 0 | |||||||||||||||
2016 | 2,500 | ||||||||||||||||
2017 | 2,500 | ||||||||||||||||
2018 | 6,000 | ||||||||||||||||
2019 | 3,000 | ||||||||||||||||
Thereafter | 25,875 | ||||||||||||||||
Total future principal payments | $ | 39,875 | |||||||||||||||
As of March 28, 2015 and September 27, 2014, the fair value of the Company’s Notes, based on Level 2 inputs, was $40.2 billion and $28.5 billion, respectively. |
Shareholders_Equity
Shareholders' Equity | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Shareholders' Equity | Note 7 – Shareholders’ Equity | ||||||||||||||||
Dividends | |||||||||||||||||
The Company declared and paid cash dividends per share during the periods presented as follows: | |||||||||||||||||
Dividends | Amount | ||||||||||||||||
Per Share | (in millions) | ||||||||||||||||
2015:00:00 | |||||||||||||||||
Second quarter | $ | 0.47 | $ | 2,734 | |||||||||||||
First quarter | 0.47 | 2,750 | |||||||||||||||
Total cash dividends declared and paid | $ | 0.94 | $ | 5,484 | |||||||||||||
2014:00:00 | |||||||||||||||||
Fourth quarter | $ | 0.47 | $ | 2,807 | |||||||||||||
Third quarter | 0.47 | 2,830 | |||||||||||||||
Second quarter | 0.44 | 2,655 | |||||||||||||||
First quarter | 0.44 | 2,739 | |||||||||||||||
Total cash dividends declared and paid | $ | 1.82 | $ | 11,031 | |||||||||||||
Future dividends are subject to declaration by the Board of Directors. | |||||||||||||||||
Share Repurchase Program | |||||||||||||||||
In 2014, the Company’s Board of Directors increased the share repurchase authorization to $90 billion of the Company’s common stock, of which $80.0 billion had been utilized as of March 28, 2015. The Company’s share repurchase program does not obligate it to acquire any specific number of shares. Under the program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). | |||||||||||||||||
The Company has entered, and in the future may enter, into accelerated share repurchase arrangements (“ASRs”) with financial institutions. In exchange for up-front payments, the financial institutions deliver shares of the Company’s common stock during the purchase periods of each ASR. The total number of shares ultimately delivered, and therefore the average repurchase price paid per share, is determined at the end of the applicable purchase period of each ASR based on the volume weighted-average price of the Company’s common stock during that period. The shares received are retired in the periods they are delivered, and the up-front payments are accounted for as a reduction to shareholders’ equity in the Company’s Condensed Consolidated Balance Sheet in the periods the payments are made. The Company reflects the ASRs as a repurchase of common stock in the period delivered for purposes of calculating earnings per share and as forward contracts indexed to its own common stock. The ASRs met all of the applicable criteria for equity classification, and therefore, were not accounted for as derivative instruments. | |||||||||||||||||
The following table shows the Company’s ASR activity and related information during the six months ended March 28, 2015 and the year ended September 27, 2014: | |||||||||||||||||
Purchase | Number of | Average | ASR | ||||||||||||||
Period End | Shares | Repurchase | Amount | ||||||||||||||
Date | (in thousands) | Price | (in millions) | ||||||||||||||
Per Share | |||||||||||||||||
August 2014 ASR | February 2015 | 81,525 (1) | $ | 110.4 | $ | 9,000 | |||||||||||
January 2014 ASR | December 2014 | 134,247 | $ | 89.39 | $ | 12,000 | |||||||||||
April 2013 ASR | March 2014 | 172,548 | $ | 69.55 | $ | 12,000 | |||||||||||
(1) | Includes 59.9 million shares delivered and retired at the beginning of the purchase period, which began in the fourth quarter of 2014, 8.3 million net shares delivered and retired in the first quarter of 2015 and 13.3 million shares delivered and retired at the end of the purchase period, which concluded in the second quarter of 2015. | ||||||||||||||||
Additionally, the Company repurchased shares of its common stock in the open market, which were retired upon repurchase, during the periods presented as follows: | |||||||||||||||||
Number of | Average | Amount | |||||||||||||||
Shares | Repurchase | (in millions) | |||||||||||||||
(in thousands) | Price | ||||||||||||||||
Per Share | |||||||||||||||||
2015:00:00 | |||||||||||||||||
Second quarter | 56,400 | $ | 124.11 | $ | 7,000 | ||||||||||||
First quarter | 45,704 | $ | 109.4 | 5,000 | |||||||||||||
Total open market common stock repurchases | 102,104 | $ | 12,000 | ||||||||||||||
2014:00:00 | |||||||||||||||||
Fourth quarter | 81,255 | $ | 98.46 | $ | 8,000 | ||||||||||||
Third quarter | 58,661 | $ | 85.23 | 5,000 | |||||||||||||
Second quarter | 79,749 | $ | 75.24 | 6,000 | |||||||||||||
First quarter | 66,847 | $ | 74.79 | 5,000 | |||||||||||||
Total open market common stock repurchases | 286,512 | $ | 24,000 | ||||||||||||||
Comprehensive_Income
Comprehensive Income | 6 Months Ended | ||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||
Comprehensive Income | Note 8 – Comprehensive Income | ||||||||||||||||||
Comprehensive income consists of two components, net income and OCI. OCI refers to revenue, expenses, and gains and losses that under GAAP are recorded as an element of shareholders’ equity but are excluded from net income. The Company’s OCI consists of foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency, net deferred gains and losses on certain derivative instruments accounted for as cash flow hedges and unrealized gains and losses on marketable securities classified as available-for-sale. | |||||||||||||||||||
The following table shows the pre-tax amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
Comprehensive Income Components | Financial Statement | March 28, | March 29, | March 28, | March 29, | ||||||||||||||
Line Item | 2015 | 2014 | 2015 | 2014 | |||||||||||||||
Unrealized (gains)/losses on derivative instruments: | |||||||||||||||||||
Foreign exchange contracts | Revenue | $ | (558 | ) | $ | 119 | $ | (1,007 | ) | $ | 303 | ||||||||
Cost of sales | (608 | ) | (141 | ) | (921 | ) | (251 | ) | |||||||||||
Other income/(expense), net | (1 | ) | 4 | (1 | ) | 14 | |||||||||||||
Interest rate contracts | Other income/(expense), net | 353 | 4 | 452 | 8 | ||||||||||||||
(814 | ) | (14 | ) | (1,477 | ) | 74 | |||||||||||||
Unrealized (gains)/losses on marketable securities | Other income/(expense), net | 56 | (60 | ) | 34 | (77 | ) | ||||||||||||
Total amounts reclassified from AOCI | $ | (758 | ) | $ | (74 | ) | $ | (1,443 | ) | $ | (3 | ) | |||||||
The following table shows the changes in AOCI by component for the six months ended March 28, 2015 (in millions): | |||||||||||||||||||
Cumulative | Unrealized | Unrealized | Total | ||||||||||||||||
Foreign | Gains/Losses | Gains/Losses | |||||||||||||||||
Currency | on Derivative | on Marketable | |||||||||||||||||
Translation | Instruments | Securities | |||||||||||||||||
Balance at September 27, 2014 | $ | (242 | ) | $ | 1,364 | $ | (40 | ) | $ | 1,082 | |||||||||
Other comprehensive income/(loss) before reclassifications | (365 | ) | 3,548 | 200 | 3,383 | ||||||||||||||
Amounts reclassified from AOCI | 0 | (1,477 | ) | 34 | (1,443 | ) | |||||||||||||
Tax effect | 119 | (356 | ) | (75 | ) | (312 | ) | ||||||||||||
Other comprehensive income/(loss) | (246 | ) | 1,715 | 159 | 1,628 | ||||||||||||||
Balance at March 28, 2015 | $ | (488 | ) | $ | 3,079 | $ | 119 | $ | 2,710 | ||||||||||
Benefit_Plans
Benefit Plans | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Benefit Plans | Note 9 – Benefit Plans | ||||||||||||||||
Stock Plans | |||||||||||||||||
The Company had 436.6 million shares reserved for future issuance under its stock plans as of March 28, 2015. RSUs granted generally vest over four years, based on continued employment, and are settled upon vesting in shares of the Company’s common stock on a one-for-one basis. Each share issued with respect to RSUs granted under the Company’s stock plans reduces the number of shares available for grant under the plan by two shares. RSUs cancelled and shares withheld to satisfy tax withholding obligations increase the number of shares available for grant under the plans utilizing a factor of two times the number of RSUs cancelled or shares withheld. Stock options count against the number of shares available for grant on a one-for-one basis. | |||||||||||||||||
Rule 10b5-1 Trading Plans | |||||||||||||||||
During the three months ended March 28, 2015, Section 16 officers Timothy D. Cook, Angela Ahrendts, Luca Maestri and Daniel Riccio had equity trading plans in place in accordance with Rule 10b5-1(c)(1) under the Exchange Act. An equity trading plan is a written document that pre-establishes the amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, including shares acquired pursuant to the Company’s employee and director equity plans. | |||||||||||||||||
Restricted Stock Units | |||||||||||||||||
A summary of the Company’s RSU activity and related information for the six months ended March 28, 2015 is as follows: | |||||||||||||||||
Number of | Weighted-Average | Aggregate | |||||||||||||||
RSUs | Grant Date Fair | Intrinsic Value | |||||||||||||||
(in thousands) | Value | (in millions) | |||||||||||||||
Balance at September 27, 2014 | 103,822 | $ | 70.98 | ||||||||||||||
RSUs granted | 38,445 | $ | 102.36 | ||||||||||||||
RSUs vested | (19,423 | ) | $ | 65.24 | |||||||||||||
RSUs cancelled | (2,980 | ) | $ | 75.15 | |||||||||||||
Balance at March 28, 2015 | 119,864 | $ | 81.87 | $ | 14,773 | ||||||||||||
RSUs that vested during the three- and six-month periods ended March 28, 2015 had fair values of $317 million and $2.0 billion, respectively, as of the vesting date. RSUs that vested during the three- and six-month periods ended March 29, 2014 had fair values of $198 million and $1.3 billion, respectively, as of the vesting date. | |||||||||||||||||
Stock Options | |||||||||||||||||
The Company had 2.3 million stock options outstanding as of March 28, 2015, with a weighted-average exercise price per share of $18.15 and weighted-average remaining contractual term of 2.6 years, substantially all of which are exercisable. The aggregate intrinsic value of the stock options outstanding as of March 28, 2015 was $239 million, which represents the value of the Company’s closing stock price on the last trading day of the period in excess of the weighted-average exercise price multiplied by the number of options outstanding. | |||||||||||||||||
The total intrinsic value of options at the time of exercise was $119 million and $367 million for the three- and six-month periods ended March 28, 2015, respectively, and $148 million and $707 million for the three- and six-month periods ended March 29, 2014, respectively. | |||||||||||||||||
Share-Based Compensation | |||||||||||||||||
The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Cost of sales | $ | 142 | $ | 110 | $ | 282 | $ | 219 | |||||||||
Research and development | 384 | 300 | 758 | 589 | |||||||||||||
Selling, general and administrative | 401 | 286 | 775 | 569 | |||||||||||||
Total share-based compensation expense | $ | 927 | $ | 696 | $ | 1,815 | $ | 1,377 | |||||||||
The income tax benefit related to share-based compensation expense was $311 million and $662 million for the three- and six-month periods ended March 28, 2015, respectively, and was $230 million and $495 million for the three- and six-month periods ended March 29, 2014, respectively. As of March 28, 2015, the total unrecognized compensation cost related to outstanding stock options and RSUs expected to vest was $8.1 billion, which the Company expects to recognize over a weighted-average period of 2.9 years. |
Commitments_and_Contingencies
Commitments and Contingencies | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Commitments and Contingencies | Note 10 – Commitments and Contingencies | ||||||||||||||||
Accrued Warranty and Indemnification | |||||||||||||||||
The following table shows changes in the Company’s accrued warranties and related costs for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Beginning accrued warranty and related costs | $ | 5,195 | $ | 3,980 | $ | 4,159 | $ | 2,967 | |||||||||
Cost of warranty claims | (1,030 | ) | (865 | ) | (2,074 | ) | (1,929 | ) | |||||||||
Accruals for product warranty | 978 | 1,253 | 3,058 | 3,330 | |||||||||||||
Ending accrued warranty and related costs | $ | 5,143 | $ | 4,368 | $ | 5,143 | $ | 4,368 | |||||||||
The Company generally does not indemnify end-users of its operating system and application software against legal claims that the software infringes third-party intellectual property rights. Other agreements entered into by the Company sometimes include indemnification provisions under which the Company could be subject to costs and/or damages in the event of an infringement claim against the Company or an indemnified third-party. However, the Company has not been required to make any significant payments resulting from such an infringement claim asserted against it or an indemnified third-party. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss with respect to indemnification of end-users of its operating system or application software for infringement of third-party intellectual property rights. The Company did not record a liability for infringement costs related to indemnification as of March 28, 2015 or September 27, 2014. | |||||||||||||||||
The Company has entered into indemnification agreements with its directors and executive officers. Under these agreements, the Company has agreed to indemnify such individuals to the fullest extent permitted by law against liabilities that arise by reason of their status as directors or officers and to advance expenses incurred by such individuals in connection with related legal proceedings. It is not possible to determine the maximum potential amount of payments the Company could be required to make under these agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each claim. However, the Company maintains directors and officers liability insurance coverage to reduce its exposure to such obligations, and payments made under these agreements historically have not been material. | |||||||||||||||||
Concentrations in the Available Sources of Supply of Materials and Product | |||||||||||||||||
Although most components essential to the Company’s business are generally available from multiple sources, a number of components are currently obtained from single or limited sources. In addition, the Company competes for various components with other participants in the markets for mobile communication and media devices and personal computers. Therefore, many components used by the Company, including those that are available from multiple sources, are at times subject to industry-wide shortage and significant pricing fluctuations that could materially adversely affect the Company’s financial condition and operating results. | |||||||||||||||||
The Company uses some custom components that are not commonly used by its competitors, and new products introduced by the Company often utilize custom components available from only one source. When a component or product uses new technologies, initial capacity constraints may exist until the suppliers’ yields have matured or manufacturing capacity has increased. If the Company’s supply of components for a new or existing product were delayed or constrained, or if an outsourcing partner delayed shipments of completed products to the Company, the Company’s financial condition and operating results could be materially adversely affected. The Company’s business and financial performance could also be materially adversely affected depending on the time required to obtain sufficient quantities from the original source, or to identify and obtain sufficient quantities from an alternative source. Continued availability of these components at acceptable prices, or at all, may be affected if those suppliers concentrated on the production of common components instead of components customized to meet the Company’s requirements. | |||||||||||||||||
The Company has entered into agreements for the supply of many components; however, there can be no guarantee that the Company will be able to extend or renew these agreements on similar terms, or at all. Therefore, the Company remains subject to significant risks of supply shortages and price increases that could materially adversely affect its financial condition and operating results. | |||||||||||||||||
Substantially all of the Company’s hardware products are manufactured by outsourcing partners that are located primarily in Asia. A significant concentration of this manufacturing is currently performed by a small number of outsourcing partners, often in single locations. Certain of these outsourcing partners are the sole-sourced suppliers of components and manufacturers for many of the Company’s products. Although the Company works closely with its outsourcing partners on manufacturing schedules, the Company’s operating results could be adversely affected if its outsourcing partners were unable to meet their production commitments. The Company’s purchase commitments typically cover its requirements for periods up to 150 days. | |||||||||||||||||
Other Off-Balance Sheet Commitments | |||||||||||||||||
Operating Leases | |||||||||||||||||
The Company leases various equipment and facilities, including retail space, under noncancelable operating lease arrangements. The Company does not currently utilize any other off-balance sheet financing arrangements. The major facility leases are typically for terms not exceeding 10 years and generally contain multi-year renewal options. As of March 28, 2015, the Company had a total of 453 retail stores. Leases for retail space are for terms ranging from five to 20 years, the majority of which are for 10 years, and often contain multi-year renewal options. As of March 28, 2015, the Company’s total future minimum lease payments under noncancelable operating leases were $5.1 billion, of which $3.4 billion related to leases for retail space. | |||||||||||||||||
Other Commitments | |||||||||||||||||
The Company utilizes several outsourcing partners to manufacture sub-assemblies for the Company’s products and to perform final assembly and testing of finished products. These outsourcing partners acquire components and build product based on demand information supplied by the Company, which typically covers periods up to 150 days. The Company also obtains individual components for its products from a wide variety of individual suppliers. Consistent with industry practice, the Company acquires components through a combination of purchase orders, supplier contracts and open orders based on projected demand information. Where appropriate, the purchases are applied to inventory component prepayments that are outstanding with the respective supplier. As of March 28, 2015, the Company had outstanding off-balance sheet third-party manufacturing commitments and component purchase commitments of $19.0 billion. | |||||||||||||||||
In addition to the commitments mentioned above, the Company had other off-balance sheet obligations of $4.1 billion as of March 28, 2015, which were comprised of commitments to acquire capital assets, including product tooling and manufacturing process equipment, and commitments related to advertising, research and development (“R&D”), Internet and telecommunications services, energy and other obligations. | |||||||||||||||||
Contingencies | |||||||||||||||||
The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully adjudicated, certain of which are discussed in Part II, Item 1 of this Form 10-Q under the heading “Legal Proceedings” and in Part II, Item 1A of this Form 10-Q under the heading “Risk Factors.” In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss in excess of a recorded accrual, with respect to loss contingencies. However, the outcome of litigation is inherently uncertain. Therefore, although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s consolidated financial statements for that reporting period could be materially adversely affected. | |||||||||||||||||
Smartflash LLC, et al., v. Apple Inc., et al. | |||||||||||||||||
On May 29, 2013, Smartflash LLC and Smartflash Technologies Limited filed an action against the Company in the United States District Court for the Eastern District of Texas, Tyler Division, alleging that the Company infringed certain patents relating to data storage and access systems. On February 24, 2015, a jury returned a verdict against the Company, and awarded damages of approximately $533 million. The Company is challenging the verdict, believes it has valid defenses and has not recorded a loss accrual at this time. | |||||||||||||||||
Apple Inc. v. Samsung Electronics Co., Ltd, et al. | |||||||||||||||||
On August 24, 2012, a jury returned a verdict awarding the Company $1.05 billion in its lawsuit against Samsung Electronics Co., Ltd and affiliated parties in the United States District Court, Northern District of California, San Jose Division. On March 6, 2014, the District Court entered final judgment in favor of the Company in the amount of approximately $930 million. Because the award is now subject to appeal, the Company has not recognized the award in its results of operations. |
Segment_Information_and_Geogra
Segment Information and Geographic Data | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Segment Information and Geographic Data | Note 11 – Segment Information and Geographic Data | ||||||||||||||||
The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable operating segments. | |||||||||||||||||
The Company manages its business primarily on a geographic basis. The Company’s reportable operating segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. The Americas segment includes both North and South America. The Europe segment includes European countries, as well as India, the Middle East and Africa. The Greater China segment includes China, Hong Kong and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries, other than those countries included in the Company’s other operating segments. Each operating segment provides similar hardware and software products and similar services. The accounting policies of the various segments are the same as those described in Note 1, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2014 Form 10-K. | |||||||||||||||||
The Company evaluates the performance of its operating segments based on net sales and operating income. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Advertising expenses are generally included in the geographic segment in which the expenditures are incurred. Operating income for each segment excludes other income and expense and certain expenses managed outside the operating segments. Costs excluded from segment operating income include various corporate expenses such as R&D, corporate marketing expenses, certain share-based compensation expenses, income taxes, various nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany transfers between segments for management reporting purposes. | |||||||||||||||||
The following table shows information by operating segment for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Americas: | |||||||||||||||||
Net sales | $ | 21,316 | $ | 17,982 | $ | 51,882 | $ | 42,771 | |||||||||
Operating income | $ | 7,186 | $ | 6,029 | $ | 17,887 | $ | 14,098 | |||||||||
Europe: | |||||||||||||||||
Net sales | $ | 12,204 | $ | 10,941 | $ | 29,418 | $ | 25,276 | |||||||||
Operating income | $ | 4,112 | $ | 3,605 | $ | 9,994 | $ | 8,228 | |||||||||
Greater China: | |||||||||||||||||
Net sales | $ | 16,823 | $ | 9,835 | $ | 32,967 | $ | 19,331 | |||||||||
Operating income | $ | 6,714 | $ | 3,541 | $ | 13,080 | $ | 6,788 | |||||||||
Japan: | |||||||||||||||||
Net sales | $ | 3,457 | $ | 4,047 | $ | 8,905 | $ | 9,092 | |||||||||
Operating income | $ | 1,699 | $ | 1,832 | $ | 4,187 | $ | 4,162 | |||||||||
Rest of Asia Pacific: | |||||||||||||||||
Net sales | $ | 4,210 | $ | 2,841 | $ | 9,437 | $ | 6,770 | |||||||||
Operating income | $ | 1,600 | $ | 904 | $ | 3,449 | $ | 2,272 | |||||||||
A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 28, 2015 and March 29, 2014 is as follows (in millions): | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Segment operating income | $ | 21,311 | $ | 15,911 | $ | 48,597 | $ | 35,548 | |||||||||
Research and development expense | (1,918 | ) | (1,422 | ) | (3,813 | ) | (2,752 | ) | |||||||||
Other corporate expenses, net | (1,115 | ) | (896 | ) | (2,260 | ) | (1,740 | ) | |||||||||
Total operating income | $ | 18,278 | $ | 13,593 | $ | 42,524 | $ | 31,056 | |||||||||
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Basis of Presentation and Preparation | Basis of Presentation and Preparation | ||||||||||||||||
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. | |||||||||||||||||
These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto for the fiscal year ended September 27, 2014, included in its Annual Report on Form 10-K as updated by the Company’s Current Report on Form 8-K dated January 28, 2015 (hereinafter, the “2014 Form 10-K”). The Company’s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company’s fiscal years 2015 and 2014 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or months refer to the Company’s fiscal years ended in September and the associated quarters or months of those fiscal years. | |||||||||||||||||
Earnings Per Share | Earnings Per Share | ||||||||||||||||
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company’s employee stock purchase plan, unvested restricted stock and unvested restricted stock units (“RSUs”). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the Company’s common stock can result in a greater dilutive effect from potentially dilutive securities. | |||||||||||||||||
The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (net income in millions and shares in thousands): | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Numerator: | |||||||||||||||||
Net income | $ | 13,569 | $ | 10,223 | $ | 31,593 | $ | 23,295 | |||||||||
Denominator: | |||||||||||||||||
Weighted-average shares outstanding | 5,793,799 | 6,123,302 | 5,818,441 | 6,197,903 | |||||||||||||
Effect of dilutive securities | 41,059 | 33,397 | 39,889 | 35,527 | |||||||||||||
Weighted-average diluted shares | 5,834,858 | 6,156,699 | 5,858,330 | 6,233,430 | |||||||||||||
Basic earnings per share | $ | 2.34 | $ | 1.67 | $ | 5.43 | $ | 3.76 | |||||||||
Diluted earnings per share | $ | 2.33 | $ | 1.66 | $ | 5.39 | $ | 3.74 | |||||||||
Potentially dilutive securities, whose effect would have been antidilutive, were not significant for the three- and six-month periods ended March 28, 2015 and the three- and six-month periods ended March 29, 2014. The Company excluded these securities from the computation of diluted earnings per share. | |||||||||||||||||
Derivative Financial Instruments | Derivative Financial Instruments | ||||||||||||||||
The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, on net investments in certain foreign subsidiaries and on certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates. | |||||||||||||||||
To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months. | |||||||||||||||||
To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. The Company designates these instruments as net investment hedges. | |||||||||||||||||
The Company may also enter into non-designated foreign currency contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. | |||||||||||||||||
The Company may enter into interest rate swaps, options, or other instruments to manage interest rate risk. These instruments may offset a portion of changes in income or expense, or changes in fair value of the Company’s long-term debt or investments. The Company designates these instruments as either cash flow or fair value hedges. The Company’s hedged interest rate transactions as of March 28, 2015 are expected to be recognized within 12 years. | |||||||||||||||||
Cash Flow Hedges | |||||||||||||||||
The effective portions of cash flow hedges are recorded in accumulated other comprehensive income (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. | |||||||||||||||||
The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net. These amounts were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014. | |||||||||||||||||
Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income/(expense), net. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three- and six-month periods ended March 28, 2015 and March 29, 2014. | |||||||||||||||||
Net Investment Hedges | |||||||||||||||||
The effective portions of net investment hedges are recorded in other comprehensive income (“OCI”) as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. These amounts were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014. | |||||||||||||||||
Fair Value Hedges | |||||||||||||||||
Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item. The ineffective portions and amounts excluded from the effectiveness testing of fair value hedges recognized were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014. | |||||||||||||||||
Non-Designated Derivatives | |||||||||||||||||
Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. The net gains and losses recognized for foreign currency forward and option contracts not designated as hedging instruments were not significant during the three- and six-month periods ended March 28, 2015 and March 29, 2014. |
Summary_of_Significant_Account2
Summary of Significant Accounting Policies (Tables) | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Computation of Basic and Diluted Earnings Per Share | The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (net income in millions and shares in thousands): | ||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Numerator: | |||||||||||||||||
Net income | $ | 13,569 | $ | 10,223 | $ | 31,593 | $ | 23,295 | |||||||||
Denominator: | |||||||||||||||||
Weighted-average shares outstanding | 5,793,799 | 6,123,302 | 5,818,441 | 6,197,903 | |||||||||||||
Effect of dilutive securities | 41,059 | 33,397 | 39,889 | 35,527 | |||||||||||||
Weighted-average diluted shares | 5,834,858 | 6,156,699 | 5,858,330 | 6,233,430 | |||||||||||||
Basic earnings per share | $ | 2.34 | $ | 1.67 | $ | 5.43 | $ | 3.76 | |||||||||
Diluted earnings per share | $ | 2.33 | $ | 1.66 | $ | 5.39 | $ | 3.74 |
Financial_Instruments_Tables
Financial Instruments (Tables) | 6 Months Ended | ||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||
Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities | The following tables show the Company’s cash and available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of March 28, 2015 and September 27, 2014 (in millions): | ||||||||||||||||||||||||||||
March 28, 2015 | |||||||||||||||||||||||||||||
Adjusted | Unrealized | Unrealized | Fair | Cash and | Short-Term | Long-Term | |||||||||||||||||||||||
Cost | Gains | Losses | Value | Cash | Marketable | Marketable | |||||||||||||||||||||||
Equivalents | Securities | Securities | |||||||||||||||||||||||||||
Cash | $ | 9,879 | $ | 0 | $ | 0 | $ | 9,879 | $ | 9,879 | $ | 0 | $ | 0 | |||||||||||||||
Level 1 (1): | |||||||||||||||||||||||||||||
Money market funds | 1,457 | 0 | 0 | 1,457 | 1,457 | 0 | 0 | ||||||||||||||||||||||
Mutual funds | 2,384 | 0 | (126 | ) | 2,258 | 0 | 2,258 | 0 | |||||||||||||||||||||
Subtotal | 3,841 | 0 | (126 | ) | 3,715 | 1,457 | 2,258 | 0 | |||||||||||||||||||||
Level 2 (2): | |||||||||||||||||||||||||||||
U.S. Treasury securities | 42,854 | 145 | (12 | ) | 42,987 | 0 | 1,791 | 41,196 | |||||||||||||||||||||
U.S. agency securities | 6,901 | 11 | (2 | ) | 6,910 | 585 | 1,056 | 5,269 | |||||||||||||||||||||
Non-U.S. government securities | 7,114 | 86 | (80 | ) | 7,120 | 41 | 271 | 6,808 | |||||||||||||||||||||
Certificates of deposit and time deposits | 3,473 | 0 | 0 | 3,473 | 1,163 | 1,252 | 1,058 | ||||||||||||||||||||||
Commercial paper | 2,956 | 0 | 0 | 2,956 | 1,364 | 1,592 | 0 | ||||||||||||||||||||||
Corporate securities | 100,658 | 427 | (370 | ) | 100,715 | 0 | 10,325 | 90,390 | |||||||||||||||||||||
Municipal securities | 942 | 5 | (1 | ) | 946 | 0 | 24 | 922 | |||||||||||||||||||||
Mortgage- and asset-backed securities | 14,782 | 75 | (19 | ) | 14,838 | 0 | 38 | 14,800 | |||||||||||||||||||||
Subtotal | 179,680 | 749 | (484 | ) | 179,945 | 3,153 | 16,349 | 160,443 | |||||||||||||||||||||
Total | $ | 193,400 | $ | 749 | $ | (610 | ) | $ | 193,539 | $ | 14,489 | $ | 18,607 | $ | 160,443 | ||||||||||||||
September 27, 2014 | |||||||||||||||||||||||||||||
Adjusted | Unrealized | Unrealized | Fair | Cash and | Short-Term | Long-Term | |||||||||||||||||||||||
Cost | Gains | Losses | Value | Cash | Marketable | Marketable | |||||||||||||||||||||||
Equivalents | Securities | Securities | |||||||||||||||||||||||||||
Cash | $ | 10,232 | $ | 0 | $ | 0 | $ | 10,232 | $ | 10,232 | $ | 0 | $ | 0 | |||||||||||||||
Level 1 (1): | |||||||||||||||||||||||||||||
Money market funds | 1,546 | 0 | 0 | 1,546 | 1,546 | 0 | 0 | ||||||||||||||||||||||
Mutual funds | 2,531 | 1 | (132 | ) | 2,400 | 0 | 2,400 | 0 | |||||||||||||||||||||
Subtotal | 4,077 | 1 | (132 | ) | 3,946 | 1,546 | 2,400 | 0 | |||||||||||||||||||||
Level 2 (2): | |||||||||||||||||||||||||||||
U.S. Treasury securities | 23,140 | 15 | (9 | ) | 23,146 | 12 | 607 | 22,527 | |||||||||||||||||||||
U.S. agency securities | 7,373 | 3 | (11 | ) | 7,365 | 652 | 157 | 6,556 | |||||||||||||||||||||
Non-U.S. government securities | 6,925 | 69 | (69 | ) | 6,925 | 0 | 204 | 6,721 | |||||||||||||||||||||
Certificates of deposit and time deposits | 3,832 | 0 | 0 | 3,832 | 1,230 | 1,233 | 1,369 | ||||||||||||||||||||||
Commercial paper | 475 | 0 | 0 | 475 | 166 | 309 | 0 | ||||||||||||||||||||||
Corporate securities | 85,431 | 296 | (241 | ) | 85,486 | 6 | 6,298 | 79,182 | |||||||||||||||||||||
Municipal securities | 940 | 8 | 0 | 948 | 0 | 0 | 948 | ||||||||||||||||||||||
Mortgage- and asset-backed securities | 12,907 | 26 | (49 | ) | 12,884 | 0 | 25 | 12,859 | |||||||||||||||||||||
Subtotal | 141,023 | 417 | (379 | ) | 141,061 | 2,066 | 8,833 | 130,162 | |||||||||||||||||||||
Total | $ | 155,332 | $ | 418 | $ | (511 | ) | $ | 155,239 | $ | 13,844 | $ | 11,233 | $ | 130,162 | ||||||||||||||
(1) | The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities. | ||||||||||||||||||||||||||||
(2) | The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. | ||||||||||||||||||||||||||||
Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities | The following tables show the Company’s cash and available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of March 28, 2015 and September 27, 2014 (in millions): | ||||||||||||||||||||||||||||
March 28, 2015 | |||||||||||||||||||||||||||||
Adjusted | Unrealized | Unrealized | Fair | Cash and | Short-Term | Long-Term | |||||||||||||||||||||||
Cost | Gains | Losses | Value | Cash | Marketable | Marketable | |||||||||||||||||||||||
Equivalents | Securities | Securities | |||||||||||||||||||||||||||
Cash | $ | 9,879 | $ | 0 | $ | 0 | $ | 9,879 | $ | 9,879 | $ | 0 | $ | 0 | |||||||||||||||
Level 1 (1): | |||||||||||||||||||||||||||||
Money market funds | 1,457 | 0 | 0 | 1,457 | 1,457 | 0 | 0 | ||||||||||||||||||||||
Mutual funds | 2,384 | 0 | (126 | ) | 2,258 | 0 | 2,258 | 0 | |||||||||||||||||||||
Subtotal | 3,841 | 0 | (126 | ) | 3,715 | 1,457 | 2,258 | 0 | |||||||||||||||||||||
Level 2 (2): | |||||||||||||||||||||||||||||
U.S. Treasury securities | 42,854 | 145 | (12 | ) | 42,987 | 0 | 1,791 | 41,196 | |||||||||||||||||||||
U.S. agency securities | 6,901 | 11 | (2 | ) | 6,910 | 585 | 1,056 | 5,269 | |||||||||||||||||||||
Non-U.S. government securities | 7,114 | 86 | (80 | ) | 7,120 | 41 | 271 | 6,808 | |||||||||||||||||||||
Certificates of deposit and time deposits | 3,473 | 0 | 0 | 3,473 | 1,163 | 1,252 | 1,058 | ||||||||||||||||||||||
Commercial paper | 2,956 | 0 | 0 | 2,956 | 1,364 | 1,592 | 0 | ||||||||||||||||||||||
Corporate securities | 100,658 | 427 | (370 | ) | 100,715 | 0 | 10,325 | 90,390 | |||||||||||||||||||||
Municipal securities | 942 | 5 | (1 | ) | 946 | 0 | 24 | 922 | |||||||||||||||||||||
Mortgage- and asset-backed securities | 14,782 | 75 | (19 | ) | 14,838 | 0 | 38 | 14,800 | |||||||||||||||||||||
Subtotal | 179,680 | 749 | (484 | ) | 179,945 | 3,153 | 16,349 | 160,443 | |||||||||||||||||||||
Total | $ | 193,400 | $ | 749 | $ | (610 | ) | $ | 193,539 | $ | 14,489 | $ | 18,607 | $ | 160,443 | ||||||||||||||
September 27, 2014 | |||||||||||||||||||||||||||||
Adjusted | Unrealized | Unrealized | Fair | Cash and | Short-Term | Long-Term | |||||||||||||||||||||||
Cost | Gains | Losses | Value | Cash | Marketable | Marketable | |||||||||||||||||||||||
Equivalents | Securities | Securities | |||||||||||||||||||||||||||
Cash | $ | 10,232 | $ | 0 | $ | 0 | $ | 10,232 | $ | 10,232 | $ | 0 | $ | 0 | |||||||||||||||
Level 1 (1): | |||||||||||||||||||||||||||||
Money market funds | 1,546 | 0 | 0 | 1,546 | 1,546 | 0 | 0 | ||||||||||||||||||||||
Mutual funds | 2,531 | 1 | (132 | ) | 2,400 | 0 | 2,400 | 0 | |||||||||||||||||||||
Subtotal | 4,077 | 1 | (132 | ) | 3,946 | 1,546 | 2,400 | 0 | |||||||||||||||||||||
Level 2 (2): | |||||||||||||||||||||||||||||
U.S. Treasury securities | 23,140 | 15 | (9 | ) | 23,146 | 12 | 607 | 22,527 | |||||||||||||||||||||
U.S. agency securities | 7,373 | 3 | (11 | ) | 7,365 | 652 | 157 | 6,556 | |||||||||||||||||||||
Non-U.S. government securities | 6,925 | 69 | (69 | ) | 6,925 | 0 | 204 | 6,721 | |||||||||||||||||||||
Certificates of deposit and time deposits | 3,832 | 0 | 0 | 3,832 | 1,230 | 1,233 | 1,369 | ||||||||||||||||||||||
Commercial paper | 475 | 0 | 0 | 475 | 166 | 309 | 0 | ||||||||||||||||||||||
Corporate securities | 85,431 | 296 | (241 | ) | 85,486 | 6 | 6,298 | 79,182 | |||||||||||||||||||||
Municipal securities | 940 | 8 | 0 | 948 | 0 | 0 | 948 | ||||||||||||||||||||||
Mortgage- and asset-backed securities | 12,907 | 26 | (49 | ) | 12,884 | 0 | 25 | 12,859 | |||||||||||||||||||||
Subtotal | 141,023 | 417 | (379 | ) | 141,061 | 2,066 | 8,833 | 130,162 | |||||||||||||||||||||
Total | $ | 155,332 | $ | 418 | $ | (511 | ) | $ | 155,239 | $ | 13,844 | $ | 11,233 | $ | 130,162 | ||||||||||||||
(1) | The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities. | ||||||||||||||||||||||||||||
(2) | The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. | ||||||||||||||||||||||||||||
Derivative Instruments at Gross Fair Value | The following tables show the Company’s derivative instruments at gross fair value as of March 28, 2015 and September 27, 2014 (in millions): | ||||||||||||||||||||||||||||
March 28, 2015 | |||||||||||||||||||||||||||||
Fair Value of | Fair Value of | Total | |||||||||||||||||||||||||||
Derivatives | Derivatives Not | Fair Value | |||||||||||||||||||||||||||
Designated as | Designated as | ||||||||||||||||||||||||||||
Hedge Instruments | Hedge Instruments | ||||||||||||||||||||||||||||
Derivative assets (1): | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 3,045 | $ | 86 | $ | 3,131 | |||||||||||||||||||||||
Interest rate contracts | $ | 329 | $ | 0 | $ | 329 | |||||||||||||||||||||||
Derivative liabilities (2): | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 27 | $ | 91 | $ | 118 | |||||||||||||||||||||||
Interest rate contracts | $ | 458 | $ | 0 | $ | 458 | |||||||||||||||||||||||
September 27, 2014 | |||||||||||||||||||||||||||||
Fair Value of | Fair Value of | Total | |||||||||||||||||||||||||||
Derivatives | Derivatives Not | Fair Value | |||||||||||||||||||||||||||
Designated as | Designated as | ||||||||||||||||||||||||||||
Hedge Instruments | Hedge Instruments | ||||||||||||||||||||||||||||
Derivative assets (1): | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 1,332 | $ | 222 | $ | 1,554 | |||||||||||||||||||||||
Interest rate contracts | $ | 81 | $ | 0 | $ | 81 | |||||||||||||||||||||||
Derivative liabilities (2): | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 41 | $ | 40 | $ | 81 | |||||||||||||||||||||||
(1) | The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets. | ||||||||||||||||||||||||||||
(2) | The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets. | ||||||||||||||||||||||||||||
Pre-Tax Gains and Losses of Derivative Instruments Designated as Cash Flow, Net Investment and Fair Value Hedges | The following tables show the pre-tax gains and losses of the Company’s derivative instruments designated as cash flow, net investment and fair value hedges on OCI and the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | ||||||||||||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||||||||||||||
Gains/(Losses) recognized in OCI – effective portion: | |||||||||||||||||||||||||||||
Cash flow hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 1,591 | $ | (121 | ) | $ | 4,176 | $ | 143 | ||||||||||||||||||||
Interest rate contracts | (429 | ) | (27 | ) | (517 | ) | (6 | ) | |||||||||||||||||||||
Total | $ | 1,162 | $ | (148 | ) | $ | 3,659 | $ | 137 | ||||||||||||||||||||
Net investment hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | (6 | ) | $ | (19 | ) | $ | 112 | $ | 5 | |||||||||||||||||||
Gains/(Losses) reclassified from AOCI into net income – effective portion: | |||||||||||||||||||||||||||||
Cash flow hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 1,166 | $ | 22 | $ | 1,928 | $ | (52 | ) | ||||||||||||||||||||
Interest rate contracts | (353 | ) | (4 | ) | (452 | ) | (8 | ) | |||||||||||||||||||||
Total | $ | 813 | $ | 18 | $ | 1,476 | $ | (60 | ) | ||||||||||||||||||||
Gains/(Losses) on derivative instruments: | |||||||||||||||||||||||||||||
Fair value hedges: | |||||||||||||||||||||||||||||
Interest rate contracts | $ | 122 | $ | 0 | $ | 239 | $ | 0 | |||||||||||||||||||||
Gains/(Losses) related to hedged items: | |||||||||||||||||||||||||||||
Fair value hedges: | |||||||||||||||||||||||||||||
Interest rate contracts | $ | (122 | ) | $ | 0 | $ | (239 | ) | $ | 0 | |||||||||||||||||||
Notional Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments | The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of March 28, 2015 and September 27, 2014 (in millions): | ||||||||||||||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||||||||||||||
Notional | Credit Risk | Notional | Credit Risk | ||||||||||||||||||||||||||
Amount | Amounts | Amount | Amounts | ||||||||||||||||||||||||||
Instruments designated as accounting hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 37,855 | $ | 3,045 | $ | 42,945 | $ | 1,333 | |||||||||||||||||||||
Interest rate contracts | $ | 18,013 | $ | 329 | $ | 12,000 | $ | 89 | |||||||||||||||||||||
Instruments not designated as accounting hedges: | |||||||||||||||||||||||||||||
Foreign exchange contracts | $ | 27,486 | $ | 86 | $ | 38,510 | $ | 222 |
Condensed_Consolidated_Financi1
Condensed Consolidated Financial Statement Details (Tables) | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Inventories | Inventories | ||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Components | $ | 537 | $ | 471 | |||||||||||||
Finished goods | 1,859 | 1,640 | |||||||||||||||
Total inventories | $ | 2,396 | $ | 2,111 | |||||||||||||
Property, Plant and Equipment, Net | Property, Plant and Equipment, Net | ||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Land and buildings | $ | 5,627 | $ | 4,863 | |||||||||||||
Machinery, equipment and internal-use software | 32,107 | 29,639 | |||||||||||||||
Leasehold improvements | 4,726 | 4,513 | |||||||||||||||
Gross property, plant and equipment | 42,460 | 39,015 | |||||||||||||||
Accumulated depreciation and amortization | (22,309 | ) | (18,391 | ) | |||||||||||||
Total property, plant and equipment, net | $ | 20,151 | $ | 20,624 | |||||||||||||
Accrued Expenses | Accrued Expenses | ||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Accrued warranty and related costs | $ | 5,143 | $ | 4,159 | |||||||||||||
Accrued taxes | 2,017 | 1,209 | |||||||||||||||
Accrued marketing and selling expenses | 1,384 | 2,321 | |||||||||||||||
Accrued compensation and employee benefits | 1,254 | 1,209 | |||||||||||||||
Deferred margin on component sales | 1,130 | 1,057 | |||||||||||||||
Other current liabilities | 11,899 | 8,498 | |||||||||||||||
Total accrued expenses | $ | 22,827 | $ | 18,453 | |||||||||||||
Other Non-Current Liabilities | Other Non-Current Liabilities | ||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Deferred tax liabilities | $ | 23,825 | $ | 20,259 | |||||||||||||
Other non-current liabilities | 5,991 | 4,567 | |||||||||||||||
Total other non-current liabilities | $ | 29,816 | $ | 24,826 | |||||||||||||
Other Income/(Expense), Net | Other Income/(Expense), Net | ||||||||||||||||
The following table shows the detail of other income/(expense), net for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | |||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, 2015 | March 29, 2014 | March 28, 2015 | March 29, 2014 | ||||||||||||||
Interest and dividend income | $ | 675 | $ | 410 | $ | 1,329 | $ | 837 | |||||||||
Interest expense | (163 | ) | (85 | ) | (294 | ) | (169 | ) | |||||||||
Other expense, net | (226 | ) | (100 | ) | (579 | ) | (197 | ) | |||||||||
Total other income/(expense), net | $ | 286 | $ | 225 | $ | 456 | $ | 471 | |||||||||
Goodwill_and_Other_Intangible_1
Goodwill and Other Intangible Assets (Tables) | 6 Months Ended | ||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||
Components of Gross and Net Intangible Asset Balances | The following table summarizes the components of gross and net intangible asset balances as of March 28, 2015 and September 27, 2014 (in millions): | ||||||||||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||||||||||
Gross | Accumulated | Net | Gross | Accumulated | Net | ||||||||||||||||||||
Carrying | Amortization | Carrying | Carrying | Amortization | Carrying | ||||||||||||||||||||
Amount | Amount | Amount | Amount | ||||||||||||||||||||||
Definite-lived and amortizable acquired intangible assets | $ | 7,672 | $ | (3,711 | ) | $ | 3,961 | $ | 7,127 | $ | (3,085 | ) | $ | 4,042 | |||||||||||
Indefinite-lived and non-amortizable acquired intangible assets | 100 | 0 | 100 | 100 | 0 | 100 | |||||||||||||||||||
Total acquired intangible assets | $ | 7,772 | $ | (3,711 | ) | $ | 4,061 | $ | 7,227 | $ | (3,085 | ) | $ | 4,142 | |||||||||||
Components of Gross and Net Intangible Asset Balances | The following table summarizes the components of gross and net intangible asset balances as of March 28, 2015 and September 27, 2014 (in millions): | ||||||||||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||||||||||
Gross | Accumulated | Net | Gross | Accumulated | Net | ||||||||||||||||||||
Carrying | Amortization | Carrying | Carrying | Amortization | Carrying | ||||||||||||||||||||
Amount | Amount | Amount | Amount | ||||||||||||||||||||||
Definite-lived and amortizable acquired intangible assets | $ | 7,672 | $ | (3,711 | ) | $ | 3,961 | $ | 7,127 | $ | (3,085 | ) | $ | 4,042 | |||||||||||
Indefinite-lived and non-amortizable acquired intangible assets | 100 | 0 | 100 | 100 | 0 | 100 | |||||||||||||||||||
Total acquired intangible assets | $ | 7,772 | $ | (3,711 | ) | $ | 4,061 | $ | 7,227 | $ | (3,085 | ) | $ | 4,142 | |||||||||||
Debt_Tables
Debt (Tables) | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Summary of Cash Flows Associated With Issuance and Maturities of Commercial Paper | The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the six months ended March 28, 2015 (in millions): | ||||||||||||||||
Maturities less than 90 days: | |||||||||||||||||
Proceeds from (repayments of) commercial paper, net | $ | 985 | |||||||||||||||
Maturities greater than 90 days: | |||||||||||||||||
Proceeds from commercial paper | 547 | ||||||||||||||||
Repayments of commercial paper | (4,040 | ) | |||||||||||||||
Maturities greater than 90 days, net | (3,493 | ) | |||||||||||||||
Total repayments of commercial paper, net | $ | (2,508 | ) | ||||||||||||||
Summary of Long-Term Debt | The following table provides a summary of the Company’s long-term debt as of March 28, 2015 and September 27, 2014: | ||||||||||||||||
March 28, 2015 | September 27, 2014 | ||||||||||||||||
Amount | Effective | Amount | Effective | ||||||||||||||
(in millions) | Interest Rate | (in millions) | Interest Rate | ||||||||||||||
Floating-rate notes due 2016 (1) | $ | 1,000 | 0.51% | $ | 1,000 | 0.51% | |||||||||||
Floating-rate notes due 2017 (2) | 1,000 | 0.33% | 1,000 | 0.31% | |||||||||||||
Floating-rate notes due 2018 (1) | 2,000 | 1.10% | 2,000 | 1.10% | |||||||||||||
Floating-rate notes due 2019 (2) | 1,000 | 0.56% | 1,000 | 0.54% | |||||||||||||
Floating-rate notes due 2020 (3) | 500 | 0.51% | 0 | 0 | |||||||||||||
Fixed-rate 0.45% notes due 2016 (1) | 1,500 | 0.51% | 1,500 | 0.51% | |||||||||||||
Fixed-rate 1.05% notes due 2017 (2) | 1,500 | 0.32% | 1,500 | 0.30% | |||||||||||||
Fixed-rate 1.00% notes due 2018 (1) | 4,000 | 1.08% | 4,000 | 1.08% | |||||||||||||
Fixed-rate 2.10% notes due 2019 (2) | 2,000 | 0.55% | 2,000 | 0.53% | |||||||||||||
Fixed-rate 1.55% notes due 2020 (3) | 1,250 | 0.50% | 0 | 0 | |||||||||||||
Fixed-rate 2.85% notes due 2021 (2) | 3,000 | 0.81% | 3,000 | 0.79% | |||||||||||||
Fixed-rate 2.15% notes due 2022 (3) | 1,250 | 0.82% | 0 | 0 | |||||||||||||
Fixed-rate 1.00% Euro-denominated notes due 2022 (4) | 1,534 | 2.94% | 0 | 0 | |||||||||||||
Fixed-rate 2.40% notes due 2023 (1) | 5,500 | 2.44% | 5,500 | 2.44% | |||||||||||||
Fixed-rate 3.45% notes due 2024 (2) | 2,500 | 0.92% | 2,500 | 0.90% | |||||||||||||
Fixed-rate 0.38% Swiss Franc-denominated notes due 2024 (5) | 915 | 0.28% | 0 | 0 | |||||||||||||
Fixed-rate 2.50% notes due 2025 (3) | 1,500 | 2.60% | 0 | 0 | |||||||||||||
Fixed-rate 1.63% Euro-denominated notes due 2026 (4) | 1,534 | 3.45% | 0 | 0 | |||||||||||||
Fixed-rate 0.75% Swiss Franc-denominated notes due 2030 (5) | 392 | 0.74% | 0 | 0 | |||||||||||||
Fixed-rate 3.85% notes due 2043 (1) | 3,000 | 3.91% | 3,000 | 3.91% | |||||||||||||
Fixed-rate 4.45% notes due 2044 (2) | 1,000 | 4.48% | 1,000 | 4.48% | |||||||||||||
Fixed-rate 3.45% notes due 2045 (3) | 2,000 | 3.58% | 0 | 0 | |||||||||||||
Total borrowings | 39,875 | 29,000 | |||||||||||||||
Unamortized discount | (80 | ) | (52 | ) | |||||||||||||
Hedge accounting fair value adjustments | 277 | 39 | |||||||||||||||
Total long-term debt | $ | 40,072 | $ | 28,987 | |||||||||||||
(1) | Tranche relates to the $17.0 billion debt issuance in the third quarter of 2013. | ||||||||||||||||
(2) | Tranche relates to the $12.0 billion debt issuance in the third quarter of 2014. | ||||||||||||||||
(3) | Tranche relates to the $6.5 billion debt issuance in the second quarter of 2015. | ||||||||||||||||
(4) | Tranche relates to Euro-denominated debt issuance of €2.8 billion in the first quarter of 2015. | ||||||||||||||||
(5) | Tranche relates to Swiss Franc-denominated debt issuance of SFr1.3 billion in the second quarter of 2015. | ||||||||||||||||
Future Principal Payments for Notes | Future principal payments for the Company’s Notes as of March 28, 2015 are as follows (in millions): | ||||||||||||||||
2015 | $ | 0 | |||||||||||||||
2016 | 2,500 | ||||||||||||||||
2017 | 2,500 | ||||||||||||||||
2018 | 6,000 | ||||||||||||||||
2019 | 3,000 | ||||||||||||||||
Thereafter | 25,875 | ||||||||||||||||
Total future principal payments | $ | 39,875 | |||||||||||||||
Shareholders_Equity_Tables
Shareholders' Equity (Tables) | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Cash Dividends Declared and Paid Per Share | The Company declared and paid cash dividends per share during the periods presented as follows: | ||||||||||||||||
Dividends | Amount | ||||||||||||||||
Per Share | (in millions) | ||||||||||||||||
2015:00:00 | |||||||||||||||||
Second quarter | $ | 0.47 | $ | 2,734 | |||||||||||||
First quarter | 0.47 | 2,750 | |||||||||||||||
Total cash dividends declared and paid | $ | 0.94 | $ | 5,484 | |||||||||||||
2014:00:00 | |||||||||||||||||
Fourth quarter | $ | 0.47 | $ | 2,807 | |||||||||||||
Third quarter | 0.47 | 2,830 | |||||||||||||||
Second quarter | 0.44 | 2,655 | |||||||||||||||
First quarter | 0.44 | 2,739 | |||||||||||||||
Total cash dividends declared and paid | $ | 1.82 | $ | 11,031 | |||||||||||||
Accelerated Share Repurchase Activity and Related Information | The following table shows the Company’s ASR activity and related information during the six months ended March 28, 2015 and the year ended September 27, 2014: | ||||||||||||||||
Purchase | Number of | Average | ASR | ||||||||||||||
Period End | Shares | Repurchase | Amount | ||||||||||||||
Date | (in thousands) | Price | (in millions) | ||||||||||||||
Per Share | |||||||||||||||||
August 2014 ASR | February 2015 | 81,525 (1) | $ | 110.4 | $ | 9,000 | |||||||||||
January 2014 ASR | December 2014 | 134,247 | $ | 89.39 | $ | 12,000 | |||||||||||
April 2013 ASR | March 2014 | 172,548 | $ | 69.55 | $ | 12,000 | |||||||||||
(1) | Includes 59.9 million shares delivered and retired at the beginning of the purchase period, which began in the fourth quarter of 2014, 8.3 million net shares delivered and retired in the first quarter of 2015 and 13.3 million shares delivered and retired at the end of the purchase period, which concluded in the second quarter of 2015. | ||||||||||||||||
Repurchases of Common Shares in Open Market | Additionally, the Company repurchased shares of its common stock in the open market, which were retired upon repurchase, during the periods presented as follows: | ||||||||||||||||
Number of | Average | Amount | |||||||||||||||
Shares | Repurchase | (in millions) | |||||||||||||||
(in thousands) | Price | ||||||||||||||||
Per Share | |||||||||||||||||
2015:00:00 | |||||||||||||||||
Second quarter | 56,400 | $ | 124.11 | $ | 7,000 | ||||||||||||
First quarter | 45,704 | $ | 109.4 | 5,000 | |||||||||||||
Total open market common stock repurchases | 102,104 | $ | 12,000 | ||||||||||||||
2014:00:00 | |||||||||||||||||
Fourth quarter | 81,255 | $ | 98.46 | $ | 8,000 | ||||||||||||
Third quarter | 58,661 | $ | 85.23 | 5,000 | |||||||||||||
Second quarter | 79,749 | $ | 75.24 | 6,000 | |||||||||||||
First quarter | 66,847 | $ | 74.79 | 5,000 | |||||||||||||
Total open market common stock repurchases | 286,512 | $ | 24,000 | ||||||||||||||
Comprehensive_Income_Tables
Comprehensive Income (Tables) | 6 Months Ended | ||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||
Pre-tax Amounts Reclassified from AOCI into Condensed Consolidated Statements of Operations | The following table shows the pre-tax amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | ||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||
Comprehensive Income Components | Financial Statement | March 28, | March 29, | March 28, | March 29, | ||||||||||||||
Line Item | 2015 | 2014 | 2015 | 2014 | |||||||||||||||
Unrealized (gains)/losses on derivative instruments: | |||||||||||||||||||
Foreign exchange contracts | Revenue | $ | (558 | ) | $ | 119 | $ | (1,007 | ) | $ | 303 | ||||||||
Cost of sales | (608 | ) | (141 | ) | (921 | ) | (251 | ) | |||||||||||
Other income/(expense), net | (1 | ) | 4 | (1 | ) | 14 | |||||||||||||
Interest rate contracts | Other income/(expense), net | 353 | 4 | 452 | 8 | ||||||||||||||
(814 | ) | (14 | ) | (1,477 | ) | 74 | |||||||||||||
Unrealized (gains)/losses on marketable securities | Other income/(expense), net | 56 | (60 | ) | 34 | (77 | ) | ||||||||||||
Total amounts reclassified from AOCI | $ | (758 | ) | $ | (74 | ) | $ | (1,443 | ) | $ | (3 | ) | |||||||
Change in Accumulated Other Comprehensive Income by Component | The following table shows the changes in AOCI by component for the six months ended March 28, 2015 (in millions): | ||||||||||||||||||
Cumulative | Unrealized | Unrealized | Total | ||||||||||||||||
Foreign | Gains/Losses | Gains/Losses | |||||||||||||||||
Currency | on Derivative | on Marketable | |||||||||||||||||
Translation | Instruments | Securities | |||||||||||||||||
Balance at September 27, 2014 | $ | (242 | ) | $ | 1,364 | $ | (40 | ) | $ | 1,082 | |||||||||
Other comprehensive income/(loss) before reclassifications | (365 | ) | 3,548 | 200 | 3,383 | ||||||||||||||
Amounts reclassified from AOCI | 0 | (1,477 | ) | 34 | (1,443 | ) | |||||||||||||
Tax effect | 119 | (356 | ) | (75 | ) | (312 | ) | ||||||||||||
Other comprehensive income/(loss) | (246 | ) | 1,715 | 159 | 1,628 | ||||||||||||||
Balance at March 28, 2015 | $ | (488 | ) | $ | 3,079 | $ | 119 | $ | 2,710 | ||||||||||
Benefit_Plans_Tables
Benefit Plans (Tables) | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Restricted Stock Activity | A summary of the Company’s RSU activity and related information for the six months ended March 28, 2015 is as follows: | ||||||||||||||||
Number of | Weighted-Average | Aggregate | |||||||||||||||
RSUs | Grant Date Fair | Intrinsic Value | |||||||||||||||
(in thousands) | Value | (in millions) | |||||||||||||||
Balance at September 27, 2014 | 103,822 | $ | 70.98 | ||||||||||||||
RSUs granted | 38,445 | $ | 102.36 | ||||||||||||||
RSUs vested | (19,423 | ) | $ | 65.24 | |||||||||||||
RSUs cancelled | (2,980 | ) | $ | 75.15 | |||||||||||||
Balance at March 28, 2015 | 119,864 | $ | 81.87 | $ | 14,773 | ||||||||||||
Summary of Share-Based Compensation Expense | The following table shows a summary of the share-based compensation expense included in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | ||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Cost of sales | $ | 142 | $ | 110 | $ | 282 | $ | 219 | |||||||||
Research and development | 384 | 300 | 758 | 589 | |||||||||||||
Selling, general and administrative | 401 | 286 | 775 | 569 | |||||||||||||
Total share-based compensation expense | $ | 927 | $ | 696 | $ | 1,815 | $ | 1,377 | |||||||||
Commitments_and_Contingencies_
Commitments and Contingencies (Tables) | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Changes in Accrued Warranties and Related Costs | The following table shows changes in the Company’s accrued warranties and related costs for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | ||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Beginning accrued warranty and related costs | $ | 5,195 | $ | 3,980 | $ | 4,159 | $ | 2,967 | |||||||||
Cost of warranty claims | (1,030 | ) | (865 | ) | (2,074 | ) | (1,929 | ) | |||||||||
Accruals for product warranty | 978 | 1,253 | 3,058 | 3,330 | |||||||||||||
Ending accrued warranty and related costs | $ | 5,143 | $ | 4,368 | $ | 5,143 | $ | 4,368 | |||||||||
Segment_Information_and_Geogra1
Segment Information and Geographic Data (Tables) | 6 Months Ended | ||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||
Summary Information by Operating Segment | The following table shows information by operating segment for the three- and six-month periods ended March 28, 2015 and March 29, 2014 (in millions): | ||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Americas: | |||||||||||||||||
Net sales | $ | 21,316 | $ | 17,982 | $ | 51,882 | $ | 42,771 | |||||||||
Operating income | $ | 7,186 | $ | 6,029 | $ | 17,887 | $ | 14,098 | |||||||||
Europe: | |||||||||||||||||
Net sales | $ | 12,204 | $ | 10,941 | $ | 29,418 | $ | 25,276 | |||||||||
Operating income | $ | 4,112 | $ | 3,605 | $ | 9,994 | $ | 8,228 | |||||||||
Greater China: | |||||||||||||||||
Net sales | $ | 16,823 | $ | 9,835 | $ | 32,967 | $ | 19,331 | |||||||||
Operating income | $ | 6,714 | $ | 3,541 | $ | 13,080 | $ | 6,788 | |||||||||
Japan: | |||||||||||||||||
Net sales | $ | 3,457 | $ | 4,047 | $ | 8,905 | $ | 9,092 | |||||||||
Operating income | $ | 1,699 | $ | 1,832 | $ | 4,187 | $ | 4,162 | |||||||||
Rest of Asia Pacific: | |||||||||||||||||
Net sales | $ | 4,210 | $ | 2,841 | $ | 9,437 | $ | 6,770 | |||||||||
Operating income | $ | 1,600 | $ | 904 | $ | 3,449 | $ | 2,272 | |||||||||
Reconciliation of Segment Operating Income to Condensed Consolidated Statements of Operations | A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 28, 2015 and March 29, 2014 is as follows (in millions): | ||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
March 28, | March 29, | March 28, | March 29, | ||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||
Segment operating income | $ | 21,311 | $ | 15,911 | $ | 48,597 | $ | 35,548 | |||||||||
Research and development expense | (1,918 | ) | (1,422 | ) | (3,813 | ) | (2,752 | ) | |||||||||
Other corporate expenses, net | (1,115 | ) | (896 | ) | (2,260 | ) | (1,740 | ) | |||||||||
Total operating income | $ | 18,278 | $ | 13,593 | $ | 42,524 | $ | 31,056 | |||||||||
Computation_of_Basic_and_Dilut
Computation of Basic and Diluted Earnings Per Share (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, except Share data in Thousands, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Numerator: | ||||
Net income | $13,569 | $10,223 | $31,593 | $23,295 |
Denominator: | ||||
Weighted-average shares outstanding | 5,793,799 | 6,123,302 | 5,818,441 | 6,197,903 |
Effect of dilutive securities | 41,059 | 33,397 | 39,889 | 35,527 |
Weighted-average diluted shares | 5,834,858 | 6,156,699 | 5,858,330 | 6,233,430 |
Basic earnings per share | $2.34 | $1.67 | $5.43 | $3.76 |
Diluted earnings per share | $2.33 | $1.66 | $5.39 | $3.74 |
Cash_and_AvailableforSale_Secu
Cash and Available-for-Sale Securities' Adjusted Cost, Gross Unrealized Gains, Gross Unrealized Losses and Fair Value Recorded as Cash and Cash Equivalents or Short-Term or Long-Term Marketable Securities (Detail) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 29, 2014 | Sep. 28, 2013 | ||
In Millions, unless otherwise specified | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | $193,400 | $155,332 | ||||
Unrealized Gains | 749 | 418 | ||||
Unrealized Losses | -610 | -511 | ||||
Fair Value | 193,539 | 155,239 | ||||
Cash and cash equivalents | 14,489 | 13,844 | 18,949 | 14,259 | ||
Short-term marketable securities | 18,607 | 11,233 | ||||
Long-term marketable securities | 160,443 | 130,162 | ||||
Cash | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 9,879 | 10,232 | ||||
Unrealized Gains | 0 | 0 | ||||
Unrealized Losses | 0 | 0 | ||||
Fair Value | 9,879 | 10,232 | ||||
Cash and cash equivalents | 9,879 | 10,232 | ||||
Short-term marketable securities | 0 | 0 | ||||
Long-term marketable securities | 0 | 0 | ||||
Level 1 | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 3,841 | [1] | 4,077 | [1] | ||
Unrealized Gains | 0 | [1] | 1 | [1] | ||
Unrealized Losses | -126 | [1] | -132 | [1] | ||
Fair Value | 3,715 | [1] | 3,946 | [1] | ||
Cash and cash equivalents | 1,457 | [1] | 1,546 | [1] | ||
Short-term marketable securities | 2,258 | [1] | 2,400 | [1] | ||
Long-term marketable securities | 0 | [1] | 0 | [1] | ||
Level 1 | Money market funds | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 1,457 | [1] | 1,546 | [1] | ||
Unrealized Gains | 0 | [1] | 0 | [1] | ||
Unrealized Losses | 0 | [1] | 0 | [1] | ||
Fair Value | 1,457 | [1] | 1,546 | [1] | ||
Cash and cash equivalents | 1,457 | [1] | 1,546 | [1] | ||
Short-term marketable securities | 0 | [1] | 0 | [1] | ||
Long-term marketable securities | 0 | [1] | 0 | [1] | ||
Level 1 | Mutual funds | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 2,384 | [1] | 2,531 | [1] | ||
Unrealized Gains | 0 | [1] | 1 | [1] | ||
Unrealized Losses | -126 | [1] | -132 | [1] | ||
Fair Value | 2,258 | [1] | 2,400 | [1] | ||
Cash and cash equivalents | 0 | [1] | 0 | [1] | ||
Short-term marketable securities | 2,258 | [1] | 2,400 | [1] | ||
Long-term marketable securities | 0 | [1] | 0 | [1] | ||
Level 2 | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 179,680 | [2] | 141,023 | [2] | ||
Unrealized Gains | 749 | [2] | 417 | [2] | ||
Unrealized Losses | -484 | [2] | -379 | [2] | ||
Fair Value | 179,945 | [2] | 141,061 | [2] | ||
Cash and cash equivalents | 3,153 | [2] | 2,066 | [2] | ||
Short-term marketable securities | 16,349 | [2] | 8,833 | [2] | ||
Long-term marketable securities | 160,443 | [2] | 130,162 | [2] | ||
Level 2 | U.S. Treasury securities | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 42,854 | [2] | 23,140 | [2] | ||
Unrealized Gains | 145 | [2] | 15 | [2] | ||
Unrealized Losses | -12 | [2] | -9 | [2] | ||
Fair Value | 42,987 | [2] | 23,146 | [2] | ||
Cash and cash equivalents | 0 | [2] | 12 | [2] | ||
Short-term marketable securities | 1,791 | [2] | 607 | [2] | ||
Long-term marketable securities | 41,196 | [2] | 22,527 | [2] | ||
Level 2 | U.S. agency securities | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 6,901 | [2] | 7,373 | [2] | ||
Unrealized Gains | 11 | [2] | 3 | [2] | ||
Unrealized Losses | -2 | [2] | -11 | [2] | ||
Fair Value | 6,910 | [2] | 7,365 | [2] | ||
Cash and cash equivalents | 585 | [2] | 652 | [2] | ||
Short-term marketable securities | 1,056 | [2] | 157 | [2] | ||
Long-term marketable securities | 5,269 | [2] | 6,556 | [2] | ||
Level 2 | Non-U.S. government securities | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 7,114 | [2] | 6,925 | [2] | ||
Unrealized Gains | 86 | [2] | 69 | [2] | ||
Unrealized Losses | -80 | [2] | -69 | [2] | ||
Fair Value | 7,120 | [2] | 6,925 | [2] | ||
Cash and cash equivalents | 41 | [2] | 0 | [2] | ||
Short-term marketable securities | 271 | [2] | 204 | [2] | ||
Long-term marketable securities | 6,808 | [2] | 6,721 | [2] | ||
Level 2 | Certificates of deposit and time deposits | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 3,473 | [2] | 3,832 | [2] | ||
Unrealized Gains | 0 | [2] | 0 | [2] | ||
Unrealized Losses | 0 | [2] | 0 | [2] | ||
Fair Value | 3,473 | [2] | 3,832 | [2] | ||
Cash and cash equivalents | 1,163 | [2] | 1,230 | [2] | ||
Short-term marketable securities | 1,252 | [2] | 1,233 | [2] | ||
Long-term marketable securities | 1,058 | [2] | 1,369 | [2] | ||
Level 2 | Commercial paper | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 2,956 | [2] | 475 | [2] | ||
Unrealized Gains | 0 | [2] | 0 | [2] | ||
Unrealized Losses | 0 | [2] | 0 | [2] | ||
Fair Value | 2,956 | [2] | 475 | [2] | ||
Cash and cash equivalents | 1,364 | [2] | 166 | [2] | ||
Short-term marketable securities | 1,592 | [2] | 309 | [2] | ||
Long-term marketable securities | 0 | [2] | 0 | [2] | ||
Level 2 | Corporate securities | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 100,658 | [2] | 85,431 | [2] | ||
Unrealized Gains | 427 | [2] | 296 | [2] | ||
Unrealized Losses | -370 | [2] | -241 | [2] | ||
Fair Value | 100,715 | [2] | 85,486 | [2] | ||
Cash and cash equivalents | 0 | [2] | 6 | [2] | ||
Short-term marketable securities | 10,325 | [2] | 6,298 | [2] | ||
Long-term marketable securities | 90,390 | [2] | 79,182 | [2] | ||
Level 2 | Municipal securities | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 942 | [2] | 940 | [2] | ||
Unrealized Gains | 5 | [2] | 8 | [2] | ||
Unrealized Losses | -1 | [2] | 0 | [2] | ||
Fair Value | 946 | [2] | 948 | [2] | ||
Cash and cash equivalents | 0 | [2] | 0 | [2] | ||
Short-term marketable securities | 24 | [2] | 0 | [2] | ||
Long-term marketable securities | 922 | [2] | 948 | [2] | ||
Level 2 | Mortgage- and asset-backed securities | ||||||
Schedule of Available-for-sale Securities [Line Items] | ||||||
Adjusted Cost | 14,782 | [2] | 12,907 | [2] | ||
Unrealized Gains | 75 | [2] | 26 | [2] | ||
Unrealized Losses | -19 | [2] | -49 | [2] | ||
Fair Value | 14,838 | [2] | 12,884 | [2] | ||
Cash and cash equivalents | 0 | [2] | 0 | [2] | ||
Short-term marketable securities | 38 | [2] | 25 | [2] | ||
Long-term marketable securities | $14,800 | [2] | $12,859 | [2] | ||
[1] | The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities. | |||||
[2] | The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
Financial_Instruments_Addition
Financial Instruments - Additional Information (Detail) (USD $) | 6 Months Ended | 12 Months Ended |
Mar. 28, 2015 | Sep. 27, 2014 | |
Financial Instruments [Line Items] | ||
Maturities of long-term marketable securities, minimum | 1 year | |
Maturities of long-term marketable securities, maximum | 5 years | |
Hedged foreign currency transactions, typical term | 12 months | |
Hedged interest rate transactions, expected period to be recognized | 12 years | |
Net cash collateral received, derivative instruments | 3,700,000,000 | 2,100,000,000 |
Reduction to derivative assets by rights of set-off associated with derivative contracts | 3,600,000,000 | 1,600,000,000 |
Reduction to derivative liabilities by rights of set-off associated with derivative contracts | 3,600,000,000 | 1,600,000,000 |
Net derivative assets (liabilities) | -859,000,000 | -549,000,000 |
Number of customers representing 10% or more of trade receivables | 1 | 2 |
Number of vendors representing a significant portion of non-trade receivables | 3 | 3 |
Trade Receivables | Credit Concentration Risk | Customer One | ||
Financial Instruments [Line Items] | ||
Concentration risk, percentage | 11.00% | 16.00% |
Trade Receivables | Credit Concentration Risk | Customer Two | ||
Financial Instruments [Line Items] | ||
Concentration risk, percentage | 13.00% | |
Trade Receivables | Credit Concentration Risk | Cellular Network Carriers | ||
Financial Instruments [Line Items] | ||
Concentration risk, percentage | 63.00% | 72.00% |
Non-Trade Receivables | Credit Concentration Risk | Vendor One | ||
Financial Instruments [Line Items] | ||
Concentration risk, percentage | 48.00% | 51.00% |
Non-Trade Receivables | Credit Concentration Risk | Vendor Two | ||
Financial Instruments [Line Items] | ||
Concentration risk, percentage | 18.00% | 16.00% |
Non-Trade Receivables | Credit Concentration Risk | Vendor Three | ||
Financial Instruments [Line Items] | ||
Concentration risk, percentage | 16.00% | 14.00% |
Derivative_Instruments_at_Gros
Derivative Instruments at Gross Fair Value (Detail) (Level 2, USD $) | Mar. 28, 2015 | Sep. 27, 2014 | ||
In Millions, unless otherwise specified | ||||
Foreign exchange contracts | Other Current Assets | ||||
Derivative assets: | ||||
Fair Value of Derivative Assets | $3,131 | [1] | $1,554 | [1] |
Foreign exchange contracts | Accrued expenses | ||||
Derivative liabilities: | ||||
Fair Value of Derivative Liabilities | 118 | [2] | 81 | [2] |
Interest rate contracts | Other Current Assets | ||||
Derivative assets: | ||||
Fair Value of Derivative Assets | 329 | [1] | 81 | [1] |
Interest rate contracts | Accrued expenses | ||||
Derivative liabilities: | ||||
Fair Value of Derivative Liabilities | 458 | [2] | ||
Derivatives Designated as Hedging Instruments | Foreign exchange contracts | Other Current Assets | ||||
Derivative assets: | ||||
Fair Value of Derivative Assets | 3,045 | [1] | 1,332 | [1] |
Derivatives Designated as Hedging Instruments | Foreign exchange contracts | Accrued expenses | ||||
Derivative liabilities: | ||||
Fair Value of Derivative Liabilities | 27 | [2] | 41 | [2] |
Derivatives Designated as Hedging Instruments | Interest rate contracts | Other Current Assets | ||||
Derivative assets: | ||||
Fair Value of Derivative Assets | 329 | [1] | 81 | [1] |
Derivatives Designated as Hedging Instruments | Interest rate contracts | Accrued expenses | ||||
Derivative liabilities: | ||||
Fair Value of Derivative Liabilities | 458 | [2] | ||
Not Designated as Hedging Instrument | Foreign exchange contracts | Other Current Assets | ||||
Derivative assets: | ||||
Fair Value of Derivative Assets | 86 | [1] | 222 | [1] |
Not Designated as Hedging Instrument | Foreign exchange contracts | Accrued expenses | ||||
Derivative liabilities: | ||||
Fair Value of Derivative Liabilities | 91 | [2] | 40 | [2] |
Not Designated as Hedging Instrument | Interest rate contracts | Other Current Assets | ||||
Derivative assets: | ||||
Fair Value of Derivative Assets | 0 | [1] | 0 | [1] |
Not Designated as Hedging Instrument | Interest rate contracts | Accrued expenses | ||||
Derivative liabilities: | ||||
Fair Value of Derivative Liabilities | $0 | [2] | ||
[1] | The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed Consolidated Balance Sheets. | |||
[2] | The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed Consolidated Balance Sheets. |
PreTax_Gains_and_Losses_of_Der
Pre-Tax Gains and Losses of Derivative Instruments Designated as Cash Flow, Net Investment and Fair Value Hedges (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Cash flow hedges | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) recognized in OCI - effective portion | $1,162 | ($148) | $3,659 | $137 |
Gains/(Losses) reclassified from AOCI into net income - effective portion | 813 | 18 | 1,476 | -60 |
Cash flow hedges | Foreign exchange contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) recognized in OCI - effective portion | 1,591 | -121 | 4,176 | 143 |
Gains/(Losses) reclassified from AOCI into net income - effective portion | 1,166 | 22 | 1,928 | -52 |
Cash flow hedges | Interest rate contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) recognized in OCI - effective portion | -429 | -27 | -517 | -6 |
Gains/(Losses) reclassified from AOCI into net income - effective portion | -353 | -4 | -452 | -8 |
Net investment hedges | Foreign exchange contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) recognized in OCI - effective portion | -6 | -19 | 112 | 5 |
Fair value hedges | Interest rate contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains/(Losses) on derivative instruments | 122 | 0 | 239 | 0 |
Gains/(Losses) related to hedged items | ($122) | $0 | ($239) | $0 |
Notional_Amounts_of_Outstandin
Notional Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments (Detail) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 |
In Millions, unless otherwise specified | ||
Derivatives Designated as Hedging Instruments | Foreign exchange contracts | ||
Derivative [Line Items] | ||
Notional Amount | $37,855 | $42,945 |
Credit Risk | 3,045 | 1,333 |
Derivatives Designated as Hedging Instruments | Interest rate contracts | ||
Derivative [Line Items] | ||
Notional Amount | 18,013 | 12,000 |
Credit Risk | 329 | 89 |
Not Designated as Hedging Instrument | Foreign exchange contracts | ||
Derivative [Line Items] | ||
Notional Amount | 27,486 | 38,510 |
Credit Risk | $86 | $222 |
Inventory_Detail
Inventory (Detail) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 |
In Millions, unless otherwise specified | ||
Inventory [Line Items] | ||
Components | $537 | $471 |
Finished goods | 1,859 | 1,640 |
Total inventories | $2,396 | $2,111 |
Property_Plant_and_Equipment_N
Property, Plant and Equipment, Net (Detail) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 |
In Millions, unless otherwise specified | ||
Property, Plant and Equipment [Line Items] | ||
Gross property, plant and equipment | $42,460 | $39,015 |
Accumulated depreciation and amortization | -22,309 | -18,391 |
Total property, plant and equipment, net | 20,151 | 20,624 |
Land and Buildings | ||
Property, Plant and Equipment [Line Items] | ||
Gross property, plant and equipment | 5,627 | 4,863 |
Machinery, Equipment and Internal-Use Software | ||
Property, Plant and Equipment [Line Items] | ||
Gross property, plant and equipment | 32,107 | 29,639 |
Leasehold Improvements | ||
Property, Plant and Equipment [Line Items] | ||
Gross property, plant and equipment | $4,726 | $4,513 |
Accrued_Expenses_Detail
Accrued Expenses (Detail) (USD $) | Mar. 28, 2015 | Dec. 27, 2014 | Sep. 27, 2014 | Mar. 29, 2014 | Dec. 28, 2013 | Sep. 28, 2013 |
In Millions, unless otherwise specified | ||||||
Schedule of Accrued Liabilities [Line Items] | ||||||
Accrued warranty and related costs | $5,143 | $5,195 | $4,159 | $4,368 | $3,980 | $2,967 |
Accrued taxes | 2,017 | 1,209 | ||||
Accrued marketing and selling expenses | 1,384 | 2,321 | ||||
Accrued compensation and employee benefits | 1,254 | 1,209 | ||||
Deferred margin on component sales | 1,130 | 1,057 | ||||
Other current liabilities | 11,899 | 8,498 | ||||
Total accrued expenses | $22,827 | $18,453 |
Other_NonCurrent_Liabilities_D
Other Non-Current Liabilities (Detail) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 |
In Millions, unless otherwise specified | ||
Schedule of Other Liabilities [Line Items] | ||
Deferred tax liabilities | $23,825 | $20,259 |
Other non-current liabilities | 5,991 | 4,567 |
Total other non-current liabilities | $29,816 | $24,826 |
Other_IncomeExpense_Net_Detail
Other Income/(Expense), Net (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Other Income Expense [Line Items] | ||||
Interest and dividend income | $675 | $410 | $1,329 | $837 |
Interest expense | -163 | -85 | -294 | -169 |
Other expense, net | -226 | -100 | -579 | -197 |
Total other income/(expense), net | $286 | $225 | $456 | $471 |
Goodwill_and_Other_Intangible_2
Goodwill and Other Intangible Assets - Additional Information (Detail) | 6 Months Ended |
Mar. 28, 2015 | |
Minimum | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Amortized acquired intangible assets with definite lives useful period (in years) | 3 years |
Maximum | |
Acquired Finite-Lived Intangible Assets [Line Items] | |
Amortized acquired intangible assets with definite lives useful period (in years) | 7 years |
Components_of_Gross_and_Net_In
Components of Gross and Net Intangible Asset Balances (Detail) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 |
In Millions, unless otherwise specified | ||
Acquired Intangible Assets Including Goodwill [Line Items] | ||
Definite-lived and amortizable acquired intangible assets, Gross Carrying Amount | $7,672 | $7,127 |
Definite-lived and amortizable acquired intangible assets, Accumulated Amortization | -3,711 | -3,085 |
Definite-lived and amortizable acquired intangible assets, Net Carrying Amount | 3,961 | 4,042 |
Indefinite-lived and non-amortizable acquired intangible assets | 100 | 100 |
Total acquired intangible assets, Net Carrying Amount | $4,061 | $4,142 |
Income_Taxes_Additional_Inform
Income Taxes - Additional Information (Detail) (USD $) | 0 Months Ended | ||
Jun. 11, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | |
Subsidiary | |||
Income Tax Contingency [Line Items] | |||
Gross unrecognized tax benefits | $4,600,000,000 | $4,000,000,000 | |
Gross unrecognized tax benefits that would affect effective tax rate, if recognized | 1,600,000,000 | 1,400,000,000 | |
Unrecognized tax benefits, gross interest and penalties accrued | $844,000,000 | $630,000,000 | |
European Commission | |||
Income Tax Contingency [Line Items] | |||
Income Tax Contingency, Number of Subsidiaries | 2 | ||
European Commission | Maximum | |||
Income Tax Contingency [Line Items] | |||
Income Tax Contingency, Period of Occurrence | 10 years |
Debt_Additional_Information_De
Debt - Additional Information (Detail) | 3 Months Ended | 6 Months Ended | 6 Months Ended | ||||||||||
Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 | Sep. 27, 2014 | Dec. 27, 2014 | Mar. 28, 2015 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Mar. 28, 2015 | Mar. 28, 2015 | Sep. 27, 2014 | |
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | 2015 Euro-Denominated Debt Issuance | 2015 Debt Issuance | 2015 Swiss Franc-Denominated Debt Issuance | Currency Swaps | Interest Rate Swaps | Maximum | Level 2 | Level 2 | |
EUR (€) | USD ($) | CHF | USD ($) | USD ($) | USD ($) | USD ($) | |||||||
Debt Instrument [Line Items] | |||||||||||||
Commercial paper | $3,799,000,000 | $3,799,000,000 | $6,308,000,000 | ||||||||||
Commercial paper, weighted-average interest rate | 0.10% | 0.10% | 0.12% | ||||||||||
Commercial paper, maturity period | 9 months | ||||||||||||
Debt instrument aggregate principal amount | 39,875,000,000 | 39,875,000,000 | 29,000,000,000 | ||||||||||
Debt instrument, face amount | 2,800,000,000 | 6,500,000,000 | 1,300,000,000 | ||||||||||
Notional Amount | 3,500,000,000 | 2,500,000,000 | |||||||||||
Interest expense | 161,000,000 | 84,000,000 | 289,000,000 | 168,000,000 | |||||||||
Debt instrument fair value | $40,200,000,000 | $28,500,000,000 |
Summary_of_Cash_Flows_Associat
Summary of Cash Flows Associated With Issuance and Maturities of Commercial Paper (Detail) (USD $) | 6 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Maturities less than 90 days: | ||
Proceeds from (repayments of) commercial paper, net | $985 | |
Maturities greater than 90 days: | ||
Proceeds from commercial paper | 547 | |
Repayments of commercial paper | -4,040 | |
Maturities greater than 90 days, net | -3,493 | |
Total repayments of commercial paper, net | ($2,508) | $0 |
Summary_of_LongTerm_Debt_Detai
Summary of Long-Term Debt (Detail) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 | ||
In Millions, unless otherwise specified | ||||
Debt Instrument [Line Items] | ||||
Total borrowings | $39,875 | $29,000 | ||
Unamortized discount | -80 | -52 | ||
Hedge accounting fair value adjustments | 277 | 39 | ||
Total long-term debt | 40,072 | 28,987 | ||
Floating-rate notes due 2016 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,000 | [1] | 1,000 | [1] |
Debt instrument effective interest rate | 0.51% | [1] | 0.51% | [1] |
Floating-rate notes due 2017 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,000 | [2] | 1,000 | [2] |
Debt instrument effective interest rate | 0.33% | [2] | 0.31% | [2] |
Floating-rate notes due 2018 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 2,000 | [1] | 2,000 | [1] |
Debt instrument effective interest rate | 1.10% | [1] | 1.10% | [1] |
Floating-rate notes due 2019 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,000 | [2] | 1,000 | [2] |
Debt instrument effective interest rate | 0.56% | [2] | 0.54% | [2] |
Floating-rate notes due 2020 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 500 | [3] | 0 | [3] |
Debt instrument effective interest rate | 0.51% | [3] | 0.00% | [3] |
Fixed-rate 0.45% notes due 2016 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,500 | [1] | 1,500 | [1] |
Debt instrument effective interest rate | 0.51% | [1] | 0.51% | [1] |
Fixed-rate 1.05% notes due 2017 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,500 | [2] | 1,500 | [2] |
Debt instrument effective interest rate | 0.32% | [2] | 0.30% | [2] |
Fixed-rate 1.00% notes due 2018 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 4,000 | [1] | 4,000 | [1] |
Debt instrument effective interest rate | 1.08% | [1] | 1.08% | [1] |
Fixed-rate 2.10% notes due 2019 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 2,000 | [2] | 2,000 | [2] |
Debt instrument effective interest rate | 0.55% | [2] | 0.53% | [2] |
Fixed-rate 1.55% notes due 2020 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,250 | [3] | 0 | [3] |
Debt instrument effective interest rate | 0.50% | [3] | 0.00% | [3] |
Fixed-rate 2.85% notes due 2021 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 3,000 | [2] | 3,000 | [2] |
Debt instrument effective interest rate | 0.81% | [2] | 0.79% | [2] |
Fixed-rate 2.15% notes due 2022 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,250 | [3] | 0 | [3] |
Debt instrument effective interest rate | 0.82% | [3] | 0.00% | [3] |
Fixed-rate 1.00% Euro-denominated notes due 2022 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,534 | [4] | 0 | [4] |
Debt instrument effective interest rate | 2.94% | [4] | 0.00% | [4] |
Fixed-rate 2.40% notes due 2023 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 5,500 | [1] | 5,500 | [1] |
Debt instrument effective interest rate | 2.44% | [1] | 2.44% | [1] |
Fixed-rate 3.45% notes due 2024 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 2,500 | [2] | 2,500 | [2] |
Debt instrument effective interest rate | 0.92% | [2] | 0.90% | [2] |
Fixed-rate 0.38% Swiss Franc-denominated notes due 2024 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 915 | [5] | 0 | [5] |
Debt instrument effective interest rate | 0.28% | [5] | 0.00% | [5] |
Fixed-rate 2.50% notes due 2025 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,500 | [3] | 0 | [3] |
Debt instrument effective interest rate | 2.60% | [3] | 0.00% | [3] |
Fixed-rate 1.63% Euro-denominated notes due 2026 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,534 | [4] | 0 | [4] |
Debt instrument effective interest rate | 3.45% | [4] | 0.00% | [4] |
Fixed-rate 0.75% Swiss Franc-denominated notes due 2030 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 392 | [5] | 0 | [5] |
Debt instrument effective interest rate | 0.74% | [5] | 0.00% | [5] |
Fixed-rate 3.85% notes due 2043 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 3,000 | [1] | 3,000 | [1] |
Debt instrument effective interest rate | 3.91% | [1] | 3.91% | [1] |
Fixed-rate 4.45% notes due 2044 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | 1,000 | [2] | 1,000 | [2] |
Debt instrument effective interest rate | 4.48% | [2] | 4.48% | [2] |
Fixed-rate 3.45% notes due 2045 | ||||
Debt Instrument [Line Items] | ||||
Debt instrument, senior notes | $2,000 | [3] | $0 | [3] |
Debt instrument effective interest rate | 3.58% | [3] | 0.00% | [3] |
[1] | Tranche relates to the $17.0 billion debt issuance in the third quarter of 2013. | |||
[2] | Tranche relates to the $12.0 billion debt issuance in the third quarter of 2014. | |||
[3] | Tranche relates to the $6.5 billion debt issuance in the second quarter of 2015. | |||
[4] | Tranche relates to Euro-denominated debt issuance of €2.8 billion in the first quarter of 2015. | |||
[5] | Tranche relates to Swiss Franc-denominated debt issuance of SFr1.3 billion in the second quarter of 2015. |
Summary_of_LongTerm_Debt_Paren
Summary of Long-Term Debt (Parenthetical) (Detail) | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | |||||
In Billions, unless otherwise specified | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Mar. 28, 2015 | Sep. 27, 2014 | Jun. 29, 2013 | Jun. 28, 2014 | Dec. 27, 2014 | Mar. 28, 2015 |
Floating-rate notes due 2016 | Floating-rate notes due 2016 | Floating-rate notes due 2017 | Floating-rate notes due 2017 | Floating-rate notes due 2018 | Floating-rate notes due 2018 | Floating-rate notes due 2019 | Floating-rate notes due 2019 | Floating-rate notes due 2020 | Floating-rate notes due 2020 | 2015 Debt Issuance | Fixed-rate 0.45% notes due 2016 | Fixed-rate 0.45% notes due 2016 | Fixed-rate 1.05% notes due 2017 | Fixed-rate 1.05% notes due 2017 | Fixed-rate 1.00% notes due 2018 | Fixed-rate 1.00% notes due 2018 | Fixed-rate 2.10% notes due 2019 | Fixed-rate 2.10% notes due 2019 | Fixed-rate 1.55% notes due 2020 | Fixed-rate 1.55% notes due 2020 | Fixed-rate 2.85% notes due 2021 | Fixed-rate 2.85% notes due 2021 | Fixed-rate 2.15% notes due 2022 | Fixed-rate 2.15% notes due 2022 | Fixed-rate 1.00% Euro-denominated notes due 2022 | Fixed-rate 1.00% Euro-denominated notes due 2022 | Fixed-rate 2.40% notes due 2023 | Fixed-rate 2.40% notes due 2023 | Fixed-rate 3.45% notes due 2024 | Fixed-rate 3.45% notes due 2024 | Fixed-rate 0.38% Swiss Franc-denominated notes due 2024 | Fixed-rate 0.38% Swiss Franc-denominated notes due 2024 | Fixed-rate 2.50% notes due 2025 | Fixed-rate 2.50% notes due 2025 | Fixed-rate 1.63% Euro-denominated notes due 2026 | Fixed-rate 1.63% Euro-denominated notes due 2026 | Fixed-rate 0.75% Swiss Franc-denominated notes due 2030 | Fixed-rate 0.75% Swiss Franc-denominated notes due 2030 | Fixed-rate 3.85% notes due 2043 | Fixed-rate 3.85% notes due 2043 | Fixed-rate 4.45% notes due 2044 | Fixed-rate 4.45% notes due 2044 | Fixed-rate 3.45% notes due 2045 | Fixed-rate 3.45% notes due 2045 | 2013 Debt Issuance | 2014 Debt Issuance | 2015 Euro-Denominated Debt Issuance | 2015 Swiss Franc-Denominated Debt Issuance | |
USD ($) | USD ($) | USD ($) | EUR (€) | CHF | |||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||
Debt instrument maturity year | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2022 | 2022 | 2023 | 2023 | 2024 | 2024 | 2024 | 2024 | 2025 | 2025 | 2026 | 2026 | 2030 | 2030 | 2043 | 2043 | 2044 | 2044 | 2045 | 2045 | |||||
Debt instrument interest rate | 0.45% | 0.45% | 1.05% | 1.05% | 1.00% | 1.00% | 2.10% | 2.10% | 1.55% | 1.55% | 2.85% | 2.85% | 2.15% | 2.15% | 1.00% | 1.00% | 2.40% | 2.40% | 3.45% | 3.45% | 0.38% | 0.38% | 2.50% | 2.50% | 1.63% | 1.63% | 0.75% | 0.75% | 3.85% | 3.85% | 4.45% | 4.45% | 3.45% | 3.45% | |||||||||||||||
Debt instrument, face amount | $6.50 | $17 | $12 | € 2.80 | 1.3 |
Debt_Instrument_Future_Princip
Debt Instrument Future Principal Payments (Detail) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 |
In Millions, unless otherwise specified | ||
Long Term Debt Maturities Repayments Of Principal [Line Items] | ||
2015 | $0 | |
2016 | 2,500 | |
2017 | 2,500 | |
2018 | 6,000 | |
2019 | 3,000 | |
Thereafter | 25,875 | |
Total future principal payments | $39,875 | $29,000 |
Summary_of_Dividends_Declared_
Summary of Dividends Declared and Paid (Detail) (USD $) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||
In Millions, except Per Share data, unless otherwise specified | Mar. 28, 2015 | Dec. 27, 2014 | Sep. 27, 2014 | Jun. 28, 2014 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 28, 2015 | Mar. 29, 2014 | Sep. 27, 2014 |
Dividends [Line Items] | |||||||||
Dividend Per Share | $0.47 | $0.47 | $0.47 | $0.47 | $0.44 | $0.44 | $0.94 | $0.88 | $1.82 |
Amount | $2,734 | $2,750 | $2,807 | $2,830 | $2,655 | $2,739 | $5,484 | $11,031 |
Shareholders_Equity_Additional
Shareholders' Equity - Additional Information (Detail) (USD $) | Mar. 28, 2015 | Sep. 27, 2014 |
Stockholders Equity Note Disclosure [Line Items] | ||
Maximum amount authorized for repurchase of common stock | $90,000,000,000 | |
Share repurchase program, utilized amount | $80,000,000,000 |
Accelerated_Share_Repurchase_A
Accelerated Share Repurchase Activity and Related Information (Detail) (USD $) | 1 Months Ended | 3 Months Ended | 7 Months Ended | 12 Months Ended | |||
Share data in Thousands, except Per Share data, unless otherwise specified | Feb. 28, 2015 | Aug. 31, 2014 | Dec. 27, 2014 | Feb. 28, 2015 | Dec. 27, 2014 | Mar. 31, 2014 | |
August 2014 ASR | |||||||
Accelerated Share Repurchases [Line Items] | |||||||
Purchase Period End Date | Feb-15 | ||||||
Number of Shares | 13,300 | 59,900 | 8,300 | 81,525 | [1] | ||
Average Repurchase Price Per Share | $110.40 | ||||||
ASR Amount | $9,000,000,000 | ||||||
January 2014 ASR | |||||||
Accelerated Share Repurchases [Line Items] | |||||||
Purchase Period End Date | Dec-14 | ||||||
Number of Shares | 134,247 | ||||||
Average Repurchase Price Per Share | $89.39 | ||||||
ASR Amount | 12,000,000,000 | ||||||
April 2013 ASR | |||||||
Accelerated Share Repurchases [Line Items] | |||||||
Purchase Period End Date | Mar-14 | ||||||
Number of Shares | 172,548 | ||||||
Average Repurchase Price Per Share | $69.55 | ||||||
ASR Amount | $12,000,000,000 | ||||||
[1] | Includes 59.9 million shares delivered and retired at the beginning of the purchase period, which began in the fourth quarter of 2014, 8.3 million net shares delivered and retired in the first quarter of 2015 and 13.3 million shares delivered and retired at the end of the purchase period, which concluded in the second quarter of 2015. |
Accelerated_Share_Repurchase_A1
Accelerated Share Repurchase Activity and Related Information (Parenthetical) (Detail) (August 2014 ASR) | 1 Months Ended | 3 Months Ended | 7 Months Ended | ||
In Thousands, unless otherwise specified | Feb. 28, 2015 | Aug. 31, 2014 | Dec. 27, 2014 | Feb. 28, 2015 | |
August 2014 ASR | |||||
Accelerated Share Repurchases [Line Items] | |||||
Number of shares repurchased and retired | 13,300 | 59,900 | 8,300 | 81,525 | [1] |
[1] | Includes 59.9 million shares delivered and retired at the beginning of the purchase period, which began in the fourth quarter of 2014, 8.3 million net shares delivered and retired in the first quarter of 2015 and 13.3 million shares delivered and retired at the end of the purchase period, which concluded in the second quarter of 2015. |
Repurchases_of_Common_Shares_i
Repurchases of Common Shares in Open Market (Detail) (Open Market Repurchases, USD $) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||||
In Millions, except Share data in Thousands, unless otherwise specified | Mar. 28, 2015 | Dec. 27, 2014 | Sep. 27, 2014 | Jun. 28, 2014 | Mar. 29, 2014 | Dec. 28, 2013 | Mar. 28, 2015 | Sep. 27, 2014 |
Open Market Repurchases | ||||||||
Stock Repurchase Program [Line Items] | ||||||||
Number of Shares | 56,400 | 45,704 | 81,255 | 58,661 | 79,749 | 66,847 | 102,104 | 286,512 |
Average Repurchase Price Per Share | $124.11 | $109.40 | $98.46 | $85.23 | $75.24 | $74.79 | ||
Amount | $7,000 | $5,000 | $8,000 | $5,000 | $6,000 | $5,000 | $12,000 | $24,000 |
Pretax_Amounts_Reclassified_fr
Pre-tax Amounts Reclassified from AOCI into Condensed Consolidated Statements of Operations (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Unrealized (gains)/losses on derivative instruments reclassified from AOCI | ($814) | ($14) | ($1,477) | $74 |
Unrealized (gains)/losses on marketable securities reclassified from AOCI | 56 | -60 | 34 | -77 |
Total amounts reclassified from AOCI | -758 | -74 | -1,443 | -3 |
Foreign exchange contracts | Revenue | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Unrealized (gains)/losses on derivative instruments reclassified from AOCI | -558 | 119 | -1,007 | 303 |
Foreign exchange contracts | Cost of sales | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Unrealized (gains)/losses on derivative instruments reclassified from AOCI | -608 | -141 | -921 | -251 |
Foreign exchange contracts | Other income/expense, net | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Unrealized (gains)/losses on derivative instruments reclassified from AOCI | -1 | 4 | -1 | 14 |
Interest rate contracts | Other income/expense, net | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Unrealized (gains)/losses on derivative instruments reclassified from AOCI | $353 | $4 | $452 | $8 |
Change_in_Accumulated_Other_Co
Change in Accumulated Other Comprehensive Income by Component (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Beginning balance | $1,082 | |||
Other comprehensive income/(loss) before reclassifications | 3,383 | |||
Amounts reclassified from AOCI | -758 | -74 | -1,443 | -3 |
Tax effect | -312 | |||
Total other comprehensive income/(loss) | 747 | 55 | 1,628 | 220 |
Ending balance | 2,710 | 2,710 | ||
Cumulative Foreign Currency Translation | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Beginning balance | -242 | |||
Other comprehensive income/(loss) before reclassifications | -365 | |||
Amounts reclassified from AOCI | 0 | |||
Tax effect | 119 | |||
Total other comprehensive income/(loss) | -246 | |||
Ending balance | -488 | -488 | ||
Unrealized Gains/Losses on Derivative Instruments | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Beginning balance | 1,364 | |||
Other comprehensive income/(loss) before reclassifications | 3,548 | |||
Amounts reclassified from AOCI | -1,477 | |||
Tax effect | -356 | |||
Total other comprehensive income/(loss) | 1,715 | |||
Ending balance | 3,079 | 3,079 | ||
Unrealized Gains/Losses on Marketable Securities | ||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||||
Beginning balance | -40 | |||
Other comprehensive income/(loss) before reclassifications | 200 | |||
Amounts reclassified from AOCI | 34 | |||
Tax effect | -75 | |||
Total other comprehensive income/(loss) | 159 | |||
Ending balance | $119 | $119 |
Benefit_Plans_Additional_Infor
Benefit Plans - Additional Information (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
Share data in Millions, except Per Share data, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares reserved for future issuance under stock plans (in shares) | 436.6 | 436.6 | ||
RSUs granted vesting period | 4 years | |||
Fair value of vested RSUs as of vesting date | $317,000,000 | $198,000,000 | $2,000,000,000 | $1,300,000,000 |
Stock options outstanding | 2.3 | 2.3 | ||
Stock options, Weighted average exercise price per share | $18.15 | $18.15 | ||
Stock options, Weighted average remaining contractual term | 2 years 7 months 6 days | |||
Stock options, Aggregate intrinsic value | 239,000,000 | 239,000,000 | ||
Total intrinsic value of options at the time of exercise | 119,000,000 | 148,000,000 | 367,000,000 | 707,000,000 |
Income tax benefit related to share-based compensation expense | 311,000,000 | 230,000,000 | 662,000,000 | 495,000,000 |
Total unrecognized compensation cost on stock options and RSUs | $8,100,000,000 | $8,100,000,000 | ||
Total unrecognized compensation cost on stock options and RSUs, weighted-average recognition period (in years) | 2 years 10 months 24 days |
Restricted_Stock_Units_Activit
Restricted Stock Units Activity and Related Information (Detail) (Restricted Stock Units, USD $) | 6 Months Ended |
In Millions, except Share data in Thousands, unless otherwise specified | Mar. 28, 2015 |
Restricted Stock Units | |
Number of Restricted Stock Units | |
Beginning Balance | 103,822 |
Restricted stock units granted | 38,445 |
Restricted stock units vested | -19,423 |
Restricted stock units cancelled | -2,980 |
Ending Balance | 119,864 |
Weighted-Average Grant Date Fair Value Per Share | |
Beginning Balance | $70.98 |
Restricted stock units granted | $102.36 |
Restricted stock units vested | $65.24 |
Restricted stock units cancelled | $75.15 |
Ending Balance | $81.87 |
Aggregate Intrinsic Value | |
Aggregate intrinsic value of Restricted stock units | $14,773 |
Summary_of_ShareBased_Compensa
Summary of Share-Based Compensation Expense (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Share-based compensation expense | $927 | $696 | $1,815 | $1,377 |
Cost of sales | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Share-based compensation expense | 142 | 110 | 282 | 219 |
Research and Development | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Share-based compensation expense | 384 | 300 | 758 | 589 |
Selling, General and Administrative | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Share-based compensation expense | $401 | $286 | $775 | $569 |
Changes_in_Accrued_Warranties_
Changes in Accrued Warranties and Related Costs (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Movement in Standard Product Warranty Accrual [Roll Forward] | ||||
Beginning accrued warranty and related costs | $5,195 | $3,980 | $4,159 | $2,967 |
Cost of warranty claims | -1,030 | -865 | -2,074 | -1,929 |
Accruals for product warranty | 978 | 1,253 | 3,058 | 3,330 |
Ending accrued warranty and related costs | $5,143 | $4,368 | $5,143 | $4,368 |
Commitments_and_Contingencies_1
Commitments and Contingencies - Additional Information (Detail) (USD $) | 6 Months Ended | ||||
Mar. 28, 2015 | Sep. 27, 2014 | Feb. 24, 2015 | Mar. 06, 2014 | Aug. 24, 2012 | |
Store | |||||
Commitments and Contingencies Disclosure [Line Items] | |||||
Purchase commitments maximum period | 150 days | ||||
Number of retail stores | 453 | ||||
Total future minimum lease payments under noncancelable operating leases | $5,100,000,000 | ||||
Outstanding off-balance sheet third party manufacturing commitments and component purchase commitments | 19,000,000,000 | ||||
Additional off-balance sheet obligations | 4,100,000,000 | ||||
Indemnification Agreement | |||||
Commitments and Contingencies Disclosure [Line Items] | |||||
Liability for infringement costs | 0 | 0 | |||
Major Facility Lease | Maximum | |||||
Commitments and Contingencies Disclosure [Line Items] | |||||
Term of leases | 10 years | ||||
Retail Space Lease | |||||
Commitments and Contingencies Disclosure [Line Items] | |||||
Total future minimum lease payments under noncancelable operating leases | 3,400,000,000 | ||||
Retail Space Lease | Maximum | |||||
Commitments and Contingencies Disclosure [Line Items] | |||||
Term of leases | 20 years | ||||
Retail Space Lease | Minimum | |||||
Commitments and Contingencies Disclosure [Line Items] | |||||
Term of leases | 5 years | ||||
Retail Space Lease | Majority | |||||
Commitments and Contingencies Disclosure [Line Items] | |||||
Term of leases | 10 years | ||||
Smartflash LLC | |||||
Commitments and Contingencies Disclosure [Line Items] | |||||
Result of legal proceedings | 533,000,000 | ||||
Samsung Electronics Co Ltd | |||||
Commitments and Contingencies Disclosure [Line Items] | |||||
Result of legal proceedings | 1,050,000,000 | ||||
Award from legal proceeding | $930,000,000 |
Summary_Information_by_Operati
Summary Information by Operating Segment (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Segment Reporting Information [Line Items] | ||||
Net sales | $58,010 | $45,646 | $132,609 | $103,240 |
Operating income | 18,278 | 13,593 | 42,524 | 31,056 |
Americas | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 21,316 | 17,982 | 51,882 | 42,771 |
Operating income | 7,186 | 6,029 | 17,887 | 14,098 |
Europe | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 12,204 | 10,941 | 29,418 | 25,276 |
Operating income | 4,112 | 3,605 | 9,994 | 8,228 |
Greater China | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 16,823 | 9,835 | 32,967 | 19,331 |
Operating income | 6,714 | 3,541 | 13,080 | 6,788 |
Japan | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 3,457 | 4,047 | 8,905 | 9,092 |
Operating income | 1,699 | 1,832 | 4,187 | 4,162 |
Rest of Asia Pacific | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 4,210 | 2,841 | 9,437 | 6,770 |
Operating income | $1,600 | $904 | $3,449 | $2,272 |
Reconciliation_of_Segment_Oper
Reconciliation of Segment Operating Income to Condensed Consolidated Statements of Operations (Detail) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 |
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Operating income | $18,278 | $13,593 | $42,524 | $31,056 |
Research and development expense | -1,918 | -1,422 | -3,813 | -2,752 |
Operating Segments | ||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Operating income | 21,311 | 15,911 | 48,597 | 35,548 |
Segment Reconciling Items | ||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Research and development expense | -1,918 | -1,422 | -3,813 | -2,752 |
Corporate Non-Segment | ||||
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] | ||||
Other corporate expenses, net | ($1,115) | ($896) | ($2,260) | ($1,740) |